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ABSTRACT
Glucose is widely recognized as the preferred energy substrate for metabolism
by granulosa cells (GCs). Yet in most cells, 2-5% of glucose is shunted through the
hexosamine biosynthesis pathway (HBP) for O-linked N-acetylglucosaminylation (OGlcNAcylation). O-GlcNAcylation is an evolutionarily-conserved, post-translational
process that modifies serine and threonine residues on a variety of proteins. OGlcNAcylation is also considered a nutrient sensor that can regulate cellular processes
such as metabolism, signal transduction, and proliferation. In this respect, OGlcNAcylation may be similar to, and possibly mediate, AMP-activated protein kinase
(AMPK) signaling and its nutrient-sensing actions. However, the occurrence of OGlcNAcylation and its relative importance to GC function has not been determined.
Here, we characterized relative O-GlcNAcylation in bovine GCs from small and large
antral follicles and determined its effects on GC proliferation.
Bovine ovary pairs morphologically staged to the mid-to-late estrous period
were used. Granulosa cells and follicular fluid were aspirated from small (3-5mm) and
large (>10mm) follicles. Freshly isolated GCs of small follicles exhibited greater
immunodetectable expression of O-GlcNAcylation and the O-GlcNAcylation enzyme,
O-GlcNAc transferase (OGT) expression than large follicles (P<0.05, n=7 ovary pairs).
Less glucose (0.4mM vs 2.2 mM, P<0.05) and more lactate (33.3mM vs 9.6mM,
P<0.05) was present in the follicular fluid of small follicles compared to large follicles
(P<0.05, n=7). Steroid profiles revealed a progesterone to estradiol ratio >10 in all
small follicle pools, indicative of highly atretic follicles. Similarly, 5 of the 7 large
follicles pools were highly atretic and 2 were intermediately atretic (>1<10). Culture of
GCs in serum free conditions revealed that inhibition of the HBP via the glutamine
fructose-6-phosphate aminotransferase (GFAT) inhibitor, DON (50µM), impaired OGlcNAcylation for both follicle sizes (P<0.05, n=5 independent expts.). The inhibitor
DON also prevented GC proliferation regardless of follicle size (P<0.05, n=4). Direct
inhibition of O-GlcNAcylation via the OGT inhibitor, OSMI-1 (50µM), prevented
proliferation of GCs from small follicles (P<0.05, n=3). Augmentation of OGlcNAcylation via the O-GlcNAcase (OGA) inhibitor, Thiamet-G (2.5µM), enhanced
O-GlcNAcylation in GCs from both follicle sizes (P<0.05, n=3) but had no effect
(P>0.05, n=3) on GC proliferation for either follicle size. Lastly, the use of the AMPK
activator, Metformin (10mM), revealed that while AMPK activation inhibited GC
proliferation from small follicles (P<0.05, n=4) as anticipated, it had no effect on OGlcNAcylation (P>0.05 n=5).
The results indicate that: 1) O-GlcNAcylation occurs in GCs of bovine antral
follicles, 2) Relative expression of O-GlcNAcylation is associated with alterations of
glucose and lactate within the follicle, 3) Disruption of O-GlcNAcylation impairs GC
proliferation, and 4) AMPK activation does not affect O-GlcNAcylation. In conclusion,
the HBP and O-GlcNAcylation in GCs constitute an alternative, potential nutrientsensing pathway to influence GC function and folliculogenesis in the bovine ovary.
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CHAPTER 1: LITERATURE REVIEW
1.1 Introduction
The ability of the dairy cow to be successfully bred, conceive, and birth a calf is an
essential part of the dairy industry. Profound understanding of both anatomy and
physiology of the female reproductive tract is a critical aspect to managing the
reproduction of the cow. Causes for reproductive failure are broadly studied in the
literature, from basic anatomy, to complex physiological interactions, which can
ultimately translate to advancements in artificial reproductive technologies. Research has
led to the development of techniques and procedures allowing producers to manipulate
the reproductive process of cows to make the animal more reproductively efficient.
1.2 Female Reproductive Anatomy
Anatomically, the female bovine reproductive tract is principally comprised of
vulva, vagina, cervix, uterus, oviducts, and the ovaries. The vulva is the external opening
of the tract leading to the vagina. The vagina is the site of copulation and semen
deposition under natural service. Cranial to the vagina is the cervix, which functions as a
barrier to prevent the entry of pathogens into the uterus, while simultaneously influencing
the passage of sperm following intromission or the expulsion of the fetus during
parturition (Mullins and Saacke, 1989). The cervix is largely comprised of smooth
muscle tissue, which constricts or dilates according to prevailing physiological conditions
and, on average, the cervix contains three cartilaginous rings (Heydon and Adams, 1979).
Additionally, the cervix produces mucous to aid in sperm transport (Heydon and Adams,
1979; Mullins and Saacke, 1989). The consistency of the mucous changes over the course
1

of the estrous cycle and, depending on the site of production, is categorized as
sialomucins, produced in the basal crypts of the cervix, or sulfomucins, produced at the
apical portions of the cervix, covering the cartilaginous rings (Chantler and Ratcliffe,
1947; Heydon and Adams, 1979). These two types of mucous provide distinct
environments: the sialomucins are of low viscosity; whereas the sulfomucins are highly
viscous (Mullins and Saacke, 1989). During intromission, sperm contacting the
sulfomucins are eliminated from the tract, while those encountering sialomucins are
further facilitated in their migration through the cervix (Heydon and Adams, 1979). The
consistency and constituents of cervical mucous changes in response to estrogens during
the estrous cycle, and with peak production of both occurring on the day of estrus
(Chantler and Ratcliffe, 1947; Marinov and Lovell, 1967; Heydon and Adams, 1979).
The cervix opens to the uterine body and its horns. The uterus also plays a critical role in
sperm transport and capacitation, while the uterine horns are the initial site of
implantation for the growing conceptus (Chavatte-Palmer and Guillomot, 2007). The
entire reproductive tract is considered a bicornuate uterus, in which the horns are much
more prominent than that of the uterine body. The paired oviducts that extend from each
uterine horn consist of an infundibulum, ampulla, and isthmus. The infundibulum is the
site of oocyte capture during ovulation, as it gently sweeps across the surface of the ovary
during the period of estrus with its finger-like fimbria funneling the cumulus oocyte
complex toward the ampulla (Li & Winuthayanon, 2017; Lombard et al., 1950). The
ampulla is the site of fertilization, wherein the oocyte and sperm unite (Li &
Winuthayanon, 2017). The isthmus is the constricted portion of the oviduct that limits
2

sperm entry during fertilization yet controls movement of the conceptus to the uterus
following fertilization. Beyond the tubular passageways of the reproductive tract, are the
ovaries, which function to mature and ovulate follicles, and subsequently maintain
pregnancy through the formation of the corpus luteum. Besides gamete production, the
ovaries produce the reproductive steroids, estradiol and progesterone, which play pivotal
roles in controlling behavioral aspects of the estrous cycle, as well as the physiological
parameters of ovulation, conception, pregnancy, and parturition.
1.3 Ovarian Anatomy and Steroidogenesis
The ovaries are the primary female reproductive organs. They are responsible for
producing eggs (i.e., oocytes), and the hormones estradiol and progesterone. The ovary
consists of thousands primordial follicles, the number of which is largely determined
during fetal development (Morita and Tilly, 1999). These follicles do not develop further
until puberty, where they then become primary follicles, many of which will never
further develop (Fair et al., 1997). The follicles themselves contain an oocyte, granulosa
cells, and theca cells. The primitive follicles present on the ovary are referred to as
primordial follicles, which are not yet activated, and consist of an immature oocyte and
one layer of surrounding granulosa cells (Morita and Tilly, 1999). The zona pellucida that
typically surrounds the oocyte has not yet formed, and theca cells have not yet been
recruited from the surrounding stroma during this time (Fair et al., 1997). The next stage
of follicle maturation, primary follicles, still contain an immature oocyte, but the
beginnings of a zona pellucida have formed and one to two layers of granulosa cells are
present (Fair et al., 1997). Secondary follicles contain two or more layers of granulosa
3

cells, show the beginnings of a theca cell layer forming, and contain a maturing oocyte
with growing zona pellucida (Fair et al., 1997; Richards et al., 2018). Tertiary follicles
contain a mature oocyte and fully formed zona pellucida. The cumulus-oocyte-complex
(COC) is now formed and clearly evident (Fair et al., 1997) and an antrum containing
follicular fluid is evident (Van Wezel et al., 1999; Rodgers and Irving-Rodgers, 2010b;
Hatzirodos et al., 2012). Follicular fluid is both an exudate of granulosa cell secretions
and blood serum. It provides the microenvironment for the follicle to grow or undergo
atresia and can influence its health. More than six layers of granulosa cells are present in
tertiary follicles, and a theca cell layer consisting of theca interna and theca externa
regions becomes obvious (Aerts and Bols, 2010). Tertiary follicles are further classified
based upon the size of the antrum, specifically small (3-5 mm), medium (6-8 mm), and
large (>8mm) antral follicles (Van Wezel et al., 1999). Once a tertiary follicle matures, it
is sometimes referred to as a Graafian follicle, a credit to the person who first
characterized its presence within the ovary (Graaf, 1672). Graafian follicles are the only
size of follicles that can undergo ovulation (Rajakoski, 1960).
As mentioned above, follicles consist of both theca and granulosa cells. Theca
cells line the basement membrane of the follicle (Young and McNeilly, 2010). Theca and
granulosa cells function together to produce estradiol, a steroidogenic process referred to
as the two-cell, two-gonadotropin theory (Chetrit et al., 1996; Fortune, 1986; Y.-X. Liu &
Hsueh, 1986). Theca cells primarily produce androstenedione (McNatty et al., 1984;
Fortune, 1986; Rodgers et al., 1986). This occurs through luteinizing hormone (LH)stimulated cholesterol uptake (Rodgers et al., 1986). The cholesterol is then transported
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to the mitochondria by LH-stimulation of steroidogenic acute regulatory protein (StAR)
(Rodgers et al., 1986). The conversion of pregnenolone occurs by cytochrome p450 side
chain cleavage enzyme (CYP11A1/P450scc), then to progesterone by 3β-hydroxysteroid
dehydrogenase (3β-HSD), and finally to androstenedione by steroid 17α-monooxygenase
(P450c17). Androstenedione can then either be transported to granulosa cells to produce
estradiol or converted to testosterone by 17β-hydroxysteroid dehydrogenase (17βHSD)
(Fortune, 1986). Testosterone can also be transported to granulosa cells. Once within the
granulosa cells, androstenedione is converted to estrone by cytochrome p450 aromatase
(CYP19A1/aromatase) and further estradiol by 17βHSD (Fortune, 1986; Skinner et al.,
2010). Alternatively, testosterone is directly aromatized into estradiol by CYP19A1
(Skinner et al., 2010). These enzymes within granulosa cells are primarily stimulated by
FSH.
Aside from the main function of producing estradiol (McNatty et al., 1984),
granulosa cells are also responsible for follicle growth and nurturing of the oocyte
(Eppig, 1994; Andrade et al., 2019). Granulosa cells directly communicate with the
growing oocyte through gap junctions and have many interactions with the oocyte to
regulate its growth, progression of meiosis, and transcriptional activity (Fair et al., 1997;
Kidder & Vanderhyden, 2010; Rodgers & Irving-Rodgers, 2010). The oocyte, in turn,
communicates with the granulosa cells, influencing their proliferation and steroid
production (Eppig, 1994). Oocytes also secrete oocyte specific factors that regulate
granulosa and theca cell functions, including growth differentiation factor 9 and bone
morphogenic protein 15 (Andrade et al. 2019). Granulosa and theca cells interact
5

together to influence the oocyte and follicle growth and the oocyte in turn communicates
with granulosa cells influencing proliferation and steroidogenesis (Kotsuji and Tominaga,
1994; Hyun et al., 2015). Additionally, granulosa cells produce inhibin that suppresses
FSH through action on the anterior pituitary gland (Cortvrindt et al., 1997). Once a
follicle ovulates, the remaining granulosa and theca cells become the corpus luteum (CL),
which produces progesterone and maintains pregnancy (Henderson and Moon, 1979;
Meidan et al., 1990).
1.4 Folliculogenesis and the Bovine Estrous Cycle
Folliculogenesis is the process during which small primordial follicles develop
and mature into large antral follicles. This occurs throughout the life of the female, but
particularly following puberty, and as part of ongoing estrous cycles. In the cow and
human, the number of follicles within the ovary, termed the ovarian reserve, is
determined during fetal development. The growth and maturation of the follicles is
divided into two categories: gonadotropin independent or pre-antral development; and,
gonadotropin dependent or antral development (Cortvrindt et al., 1997; Knight & Glister,
2001; Roche, 1996; Williams & Erickson, 2000). During follicular development,
follicles are further divided into different stages based upon their histological features, as
described previously. Growth of follicles from the primordial stage through the secondary
stage is gonadotropin independent, and is characterized by the growth and differentiation
of the cells within the follicle and oocyte (Gulyas et al., 1977; Oktay et al., 1998;
Williams & Erickson, 2000). Follicles that continue to grow to the tertiary stage, forming
an antrum, are under the influence of gonadotropin stimulations (Oktay et al., 1998).
6

Gonadotropin-induced growth is principally characterized by the increase in size of the
follicle rather than differentiation of cellular constituents (Williams & Erickson, 2000).
Follicular development occurs throughout estrous cycles. The bovine estrous
cycle is approximately 21 days long and can be descriptively divided into the follicular
and luteal phases. These two phases are then further subcategorized into metestrus,
diestrus, proestrus, and estrus. Each estrous cycle is comprised of two to three follicular
waves of growth in cows (Ginther et al., 1989; Sirois & Fortune, 1988). At the start of
each cycle, a cohort of antral follicles is recruited to then undergo selection, as described
above. Numerous follicles are typically recruited in the cohort (Ginther et al., 1996) and
some of these follicles will be selected to continue to grow, while others undergo atresia.
This process has been extensively studied (Ginther et al., 1996; Ginther et al., 1999;
Ireland et al., 2000; Lucy, 2018; Quirk et al., 1986; Sirois & Fortune, 1988; Webb &
Campbell, 2007), but a clear mechanism to explain follicular fate has not been
determined. During a fairly well-defined window of time (~8 hours), however, one of the
selected follicles continues its’ growth, and is called the dominant follicle; while others
cease growing and are referred to as the subordinate follicles (Ginther et al., 1996;
Ginther et al., 1997, 2001). Once dominance is achieved during the first follicular wave,
the dominant follicle also regresses, triggering an onset of a second follicular wave
(Ginther et al., 1996; Sunderland et al., 1994). The CL that forms following ovulation
remains functional during the first and possibly the second follicular wave. The
progesterone produced from the corpus luteum inhibits an LH surge that otherwise would
trigger ovulation of these dominant follicles (Schams et al., 1977; Calder et al., 1999). As
7

dominance is achieved during the second or third follicular wave, the decline of
progesterone coincident with regression of the CL, enables the dominant follicle to
respond to surging concentrations of LH and will ovulate (Kaneko et al., 1995; Beg and
Ginther, 2006). The site of rupture of the follicle becomes the newly formed CL
(sometimes referred to as a corpus hemorrhagicum) of the next estrous cycle. It continues
to grow and secretes progesterone to sustain a pregnancy should conception occur
(Henderson and Moon, 1979; Meidan et al., 1990). In the absence of conception, the
corpus luteum undergoes spontaneous regression, eventually forming scar tissue called a
corpus albicans (Davis et al., 1987).
Estrus, known as standing heat, is often defined as Day 0 of the estrous cycle and
precedes ovulation. Key hormones regulate the estrous cycle and include; gonadotropin
releasing hormone (GnRH), follicle stimulating hormone (FSH), LH, progesterone,
estradiol, inhibin, and prostaglandin F2α (PGF). GnRH is released from the
hypothalamus and stimulates the release of LH and FSH from the anterior pituitary
(Schally et al., 1971; Marian and Conn, 1979). FSH secretion coincides with the
beginning of each follicular wave and is thought to aid in the growth of developing
follicles during recruitment (Ginther et al., 1996; Ginther et al., 1997). However, FSH
secretion is not sustained throughout the cycle, and so growing follicles must rely on LH
secretion and responsiveness for continued growth (Price & Webb, 1988; Xu et al.,
1995). The follicles that remain responsive to both FSH and LH will continue to grow
during follicular waves, whereas those lacking responsiveness to LH will cease growing
and undergo atresia (Campbell et al., 2003; Ginther et al., 1996; Ginther et al., 2001;
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Webb & Campbell, 2007). Inhibin is also produced by growing follicles and suppresses
FSH secretion, particularly during the process of follicle selection (Price and Webb,
1988; Beard et al., 1990; Glister et al., 2001). LH is secreted in a pulsatile manner
throughout the cycle, surging only at the time of ovulation, and triggering ovulation to
occur (Beck and Convey, 1977; Schams et al., 1977). However, for an LH surge to occur,
a threshold of estradiol secretion must first be met, stimulating LH secretion in a positive
feedback loop (Webb and Campbell, 2007). Estradiol is produced by growing follicles,
with the amount produced by each follicle increasing concomitantly with follicle size.
Once ovulation occurs, a corpus luteum (CL) will form at the site of ovulation. The CL
functions to maintain pregnancy by producing progesterone (Henderson and Moon, 1979;
Meidan et al., 1990). If pregnancy does not occur, PGF produced by the uterine
endometrium will induce regression of the CL (Davis et al., 1987). PGF causes luteolytic
effects such as the decrease in progesterone production and the elimination of luteal
tissue (Davis et al., 1987; Miyamoto and Shirasuna, 2009).
1.5 Postpartum Cyclicity
For a relatively short period of time following parturition, dairy cows exhibit
anestrus to allow for uterine involution and repair (Peter et al., 2009). This period of
anestrus is expected, and typically lasts around 30 days. Following parturition, most of
the cow’s intake of energy is shunted towards lactation- a metabolically demanding
process that requires large amounts of energy (Montiel and Ahuja, 2005). Other equally
demanding functions, such as reproduction, are not the priority for nutrient utilization.
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Thus, many metabolic changes occur in the cow which cause certain individuals to
remain in a state of anestrus for an extended time during the postpartum period.
Typically, high producing dairy cows exhibit anestrous or anovulation for longer
periods of time than their lower producing counterparts (Peter et al., 2009). In some
sense, lactation alone contributes to this anovulation. For a time, it was widely accepted
that a suckling calf or mammary stimulation causes inhibition of gonadotropin release
from the anterior pituitary, thus dysregulating hormonal actions of FSH and LH (Montiel
and Ahuja, 2005). However, others suggest that for dairy cows, mammary stimulation
alone is insufficient to cause the anestrus period (Williams et al., 1993). As dairy cows
are not typically in contact with their calves postpartum, lactation remains the primary
contributor of anestrus.
During the transition period (i.e., the period from the non-lactating, dry period
into lactation), it is common for dry matter feed intake of dairy cows to decline, thus
restricting the amount of energy and nutrients available to the animal (Butler & Smith,
2010). It is also clear that postpartum nutrition plays a critical role in the resumption of
reproductive cyclicity in cows because anestrus can result from negative energy balance
(NEB) (Beam & Butler, 1998). When the animal is unable to consume sufficient energy
to meet her own body’s energy demands, NEB occurs (Bauman and Bruce Currie, 1980).
This phenomenon is also associated with a disruption or absence of GnRH pulses, which
impair FSH and LH secretion (True et al., 2011). Other theories about acyclicity relate to
the metabolic profile of follicular fluid and its impacts on follicular cells (i.e., granulosa
cells, theca cells, oocyte).
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The components of ovarian follicular fluid may be a good indication of relative
systemic metabolic status of the cow during the postpartum period (Butler et al., 2006;
Cheong et al., 2016; Leroy et al., 2008; Leroy, et al., 2004; Shehab-El-Deen et al., 2010;
Staples et al., 1990; Wankhade et al., 2017). Follicular fluid is an exudate of blood serum
and the secretory products of follicular cells. As metabolic changes occur in the
postpartum dairy cow from NEB or other physiological demands (e.g., stress, infection),
they are often translated into alterations of constituents of the follicular fluid (Katz et al.,
2010; Cheong et al., 2016; Yenuganti et al., 2016; Sharma et al., 2019). Follicular fluid
provides the microenvironment in which the granulosa cells and oocyte grow and mature;
whereas harmful components within the follicular fluid could negatively impact these
cells. For instance, biochemical changes in high producing, postpartum dairy cows are
mirrored by constituent components in the follicular fluid (Forde et al., 2016; Leroy et al.,
2004). In particular, glucose, total protein, triglycerides and total cholesterol decrease in
the follicular fluid following parturition; whereas, serum urea, beta hydroxybutyrate
(BHBA), and non-esterified fatty acids increase. In general, these observations are
consistent with the relative changes of these same metabolites measured in the serum of
systemic blood (Leroy et al., 2004a; Forde et al., 2016). Glucose is accepted as the
preferred energy source of granulosa cells, which in turn nurtures the oocyte and provides
for follicular growth, maturation, and steroidogenesis. However, the concentration of
glucose in follicular fluid is greater than that seen in serum, suggesting the follicle is
potentially protected from hypoglycemic conditions often seen in postpartum cows
(Leroy et al., 2004a). Collectively, these studies provide groundwork for future
11

investigations, because all of the measured metabolites described here have the potential
to directly influence follicular function. Beyond glucose, other components of follicular
fluid also impact folliculogenesis, especially during the postpartum period. For example,
low cholesterol availability limits steroidogenesis during the postpartum period because it
is the precursor to all steroid hormones (Shehab-El-Deen et al., 2010). The serum
markers, BHBA and NEFA, are used to identify animals in NEB and have detrimental
effects on follicles, cell proliferation and steroidogenesis (Jorritsma et al., 2004; Leroy et
al., 2005) .
In recent work focused on the steroid hormone profile of follicles of early
postpartum cows, new insights have been gained. For instance, Cheong and coworkers
discovered that follicles during the early postpartum period may be steroidogenically
insufficient (Cheong et al., 2016). Studies prior to this determined that cows that ovulate
the first dominant follicle postpartum have higher circulating concentrations of estradiol
than those that fail to ovulate (Beam and Butler, 1997, 1998; Butler et al., 2006; Katz et
al., 2010). The Cheong study evaluated whether the decreased estradiol of nonovulatory
follicles was attributed to deficiencies in theca or granulosa function (Cheong et al.,
2016). Ultimately, they determined theca cell function is impaired as a consequence of
reduced LH pulse frequency (Cheong et al., 2016). Similar studies attribute the
impairment to insulin resistance (Canfield and Butler, 1990). It is likely that many dairy
cows exhibit postpartum insulin resistance, an inability of muscle, fat, and liver cells to
respond to insulin. Glucose uptake in most cells is insulin dependent (Ebeling et al.,
1998). Cells unable to obtain glucose develop an insulin resistant state (Ebeling et al.,
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1998). Consequently, systemic glucose levels remain high while the pancreas continues
to produce more insulin for glucose uptake. In dairy cows, insulin resistance develops
during pregnancy or lactation, but the mechanisms are not fully understood (De Koster
and Opsomer, 2013). Nevertheless, this decreased sensitivity to insulin delays resumption
of ovarian cyclicity, ovulation, and steroid production (Cheong et al., 2016). In humans,
granulosa cells exhibit insulin resistance (Coffler et al., 2003), but this phenomena has
not yet been directly studied in dairy cows.
Insulin increases granulosa and theca cell steroidogenesis by enhancing
responsiveness to FSH and LH (Poretsky and Kalin, 1987). Thus, insulin resistance likely
contributes to the decreased steroidogenic capacity of the postpartum follicle. Postpartum
diets for cows that favor increased serum insulin concentrations also augment ovulation
and conception rates at first service (Gong et al., 2002). Conversely, systemic insulin
resistance impairs estradiol production by the dominant follicle and causes anovulation
(Cheong et al., 2016). As low glucose and insulin concentrations are typically observed
during postpartum NEB, low insulin-like growth factor-1 (IGF-1) and high growth
hormone (GH) concentrations are also observed. In a state of low insulin and IGF-1, the
cow remains hypoglycemic (Lucy, 2016). All of these physiological disruptions lead to
compromised steroidogenic capacity of the dominant follicles, which commonly occurs
during the postpartum period, and results in anovulation.
1.6 Glucose Metabolism in Granulosa cells
Glucose is the preferred energy substrate for granulosa cell metabolism (Campbell
et al., 2010). Glucose provides important substrates for ATP production, cell signaling,
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and cell maintenance. Granulosa cells primarily obtain glucose by facilitated diffusion
and activation of the GLUT transporters 1,2, 3, and 4. These transporters are expressed in
granulosa and theca cells of antral follicles, suggesting multiple pathways for glucose
uptake (Williams et al., 2001; Campbell et al., 2010; Zhang et al., 2012). The glucose is
then metabolized through glycolysis, the pentose phosphate pathway, the polyol pathway,
and the hexosamine biosynthesis pathway (HBP) (Kim et al., 2010). Quantitative
differences in ovarian arterial and venous concentrations of glucose indicate that large
amounts of glucose are metabolized by the follicle (Rabiee et al., 1997; Scaramuzzi et al.,
2010). When compared to other monosaccharides such as fructose and galactose, glucose
has the greatest capacity to promote cell proliferation and estradiol production (Campbell
et al., 2010). Glucose is also more potent than lactate or pyruvate in promoting granulosa
cell proliferation and survival (Nandi et al., 2008; Hamid et al., 2011). A large
accumulation of lactate in follicular fluid suggests that the follicle and granulosa cells, in
particular, preferentially metabolize glucose through glycolysis rather than oxidative
metabolism (Leroy et al., 2004b; Orsi et al., 2005a; Nandi et al., 2007, 2008). Campbell
and coworkers found that in sheep granulosa cells, glucose is metabolized to lactate (i.e.,
glycolytic metabolism), and is the preferred pathway for gonadotropin-induced
differentiation (Campbell et al., 2010). In other species such as pigs, granulosa cells of
small antral follicles undergo rapid cell proliferation, which is accompanied by a
metabolic shift away from aerobic respiration (Costermans et al., 2019). This
phenomenon, known as the Warburg Effect, is commonly observed in rapidly
proliferating cells, including, cancer cells, wherein accelerated conversion of glucose to
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lactate occurs (Warburg, 1925). In the Costermans study (2019), as small follicles grew
to large follicles, the rate of granulosa cell proliferation diminished overtime. However,
granulosa cells of large follicles also express maturation markers, including IGF-1, and
angiopoetin-1, alluding to their high degree of differentiation (Costermans et al., 2019).
Interestingly, glucose utilization by granulosa cells of preantral follicles is stimulated by
paracrine factors of oocytes, which favor glycolysis and do not respond to TCA-cycle
stimulating factors (Sugiura et al., 2005).
The glycolytic rate of granulosa cells is modulated by gonadotropins (Allen et al.,
1981; Boland et al., 1993, 1994). Specifically, FSH stimulates lactate and estradiol
secretion; whereas, LH stimulates lactate production but impairs estradiol secretion and
ovulation rate (Boland et al., 1993). Studies have also focused on the role of
gonadotropins on glucose uptake. Gonadotropins stimulate glucose uptake in part by
regulating facilitated diffusion (Allen et al., 1981). In whole ovary cultures, FSH and LH
stimulate glucose uptake (Armstrong and Greep, 1962; Ahrén and Kostyo, 1963;
Hamberger and Ahrén, 1967; Armstrong, 1968), which also occurs in granulosa cells
(Boland et al., 1994).
The glucose transporters, GLUT 1, 2, 3 and 4 are regulated by a variety of
reproductive hormones. Both FSH and IGF-1 stimulate GLUT1 (Kodaman and Behrman,
1999). FSH stimulates lactate production, through upregulation of glycolytic metabolism
(Hillier et al., 1985). LH stimulates both glucose uptake and glycolysis in granulosa cells.
When treated with LH, glycolytic enzymes including hexokinase and PFK, are
upregulated in granulosa cells (Flint and Denton, 1969). Glucose uptake in granulosa
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cells occurs by interleukin-1 stimulation of GLUT1 and 3 (Kol et al., 1997) and by
insulin/IGF-1 stimulation of GLUT 4 (Dupont and Scaramuzzi, 2016). In the case of
insulin/IGF-1, GLUT 4 is mobilized to the plasma membrane via an IP3-mediated
cascade (Dupont and Scaramuzzi, 2016). Stimulation of the cAMP/ PKA pathway by
glucagon or norepinephrine also regulates glucose uptake (in this instance inhibits) in
granulosa cells via GLUT 2 (Zhang et al., 2012). Essentially, PKA phosphorylates GLUT
2, which then suppresses GLUT2 activity and inhibits glucose uptake (Zhang et al.,
2012).
Progesterone and estrogen influence glucose uptake in a variety of tissues, but
evidence in granulosa cells is not conclusive. In other cell types, progesterone impairs
glucose uptake indirectly by negating insulin effects. For example, progesterone
suppresses IRS-1 receptors and downregulates the PI3K pathway in adipocytes (Wada et
al., 2010). Estrogen seems to have opposing effects on glucose uptake. In one study,
estrogen decreased glucose uptake; but in the presence of insulin, increased glucose
uptake (Shamoon and Felig, 1974). Stimulation of the estrogen receptor α (ERα)
stimulates insulin signaling and GLUT4 expression, thus increasing glucose uptake
(Gupte et al., 2015). Conversely, actions of estrogen receptor β(ERβ) suppress GLUT4
expression and decreases glucose uptake (Gupte et al., 2015). Collectively, glucose
uptake of granulosa cells is mediated by many hormones and signaling pathways, leaving
room for further research to determine the regulation of glucose metabolism in granulosa
cells.
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1.7 Nutrient Sensing Pathways in Granulosa Cells
Several pathways that monitor nutrient availability, also referred to as nutrient
sensing pathways, are active within granulosa cells and regulate many cellular activities.
Such pathways include the insulin/insulin like growth factor-1 (IIS), the mechanistic
target of rapamycin (mTOR), and AMP-activated mitogen protein kinase (AMPK)
pathways. Insulin signaling mediates both granulosa cell proliferation and steroid
production. The IIS pathway is influenced by prevailing insulin concentrations, which are
altered in response to circulating nutrient availability and the cell’s metabolic demands.
Insulin concentrations fluctuate following stimulation or repression of pancreatic β cells,
and respond to circulating amounts of glucose, specific amino acids free fatty acids, and
various hormones (Fu et al., 2013). Insulin stimulates granulosa cell proliferation, as well
as FSH- and LH-induced steroidogenesis (Campbell et al., 1995). Another energy sensor,
the mTOR pathway, is reliant on growth factors, cytokines, oxygen availability, amino
acids, and signals from IIS and AMPK to affect its activity (Saxton and Sabatini, 2017).
In granulosa cells, mTOR stimulates granulosa cell proliferation, prevents atresia and
promotes overall follicle growth because its inhibition impairs these effects (Yaba et al.,
2008). The AMPK pathway is a highly conserved energy sensor responsive to
endogenous levels of ADP, AMP and calcium. It is activated by the lack of availability of
these constituents, and then stimulates glucose and fatty acid uptake, glycolysis, βoxidation, and mitochondrial biogenesis (Hardie et al., 2012; Bertoldo et al., 2015).
Concomitantly, AMPK down-regulates pathways that synthesize lipids, carbohydrates,
proteins or ribosomal RNA to conserve cellular energy (Hardie et al., 2012; Bertoldo et
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al., 2015). Interestingly, in granulosa cells, AMPK activation opposes the actions of IIS
and mTOR. Specifically, it suppresses FSH and IGF-1 induced cell proliferation and
steroidogenesis (Tosca et al., 2005). In non-ovarian cell types, the AMPK pathway is
linked to another nutrient sensing pathway of interest to the current study, the
hexosamine biosynthesis pathway and O-GlcNAcylation. The two pathways influence
each other as AMPK phosphorylates the very enzymes required for O-GlcNAcylation (Li
et al., 2007; Eguchi et al., 2009a; Gélinas et al., 2018). However, AMPK can also be OGlcNAcylated (Luo et al., 2007; Bullen et al., 2014; Xu et al., 2014; Gélinas et al., 2018),
indicating the two energy sensors regulate activities of each other. It is the novelty of OGlcNAcylation and its nutrient sensing role within cells that make it novel to investigate
in the context of granulosa cells function, which is the subject of the current study.

1.8 O-GlcNAcylation
O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a form of
glycosylation in which sugar moieties are added to hydroxyl groups of serine and
threonine residues of cellular proteins that might otherwise undergo phosphorylation
(Bond and Hanover, 2015). It is a highly conserved posttranslational modification that
occurs through the hexosamine biosynthesis pathway, an alternate route for glucose
metabolism in the cell (Hart and Akimoto, 2009). In fact, 2-5% of all glucose in the cell
is metabolized through the HBP (Wells et al., 2003). O-GlcNAcylation is principally
regulated by two enzymes that function in a cyclical manner, similar to the process of
phosphorylation and dephosphorylation. The enzyme O-GlcNAc transferase (OGT) adds
the N-acetylglucosamine (GlcNAc) sugar from the donor substrate, UDP-GlcNAc, to
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proteins; whereas O-GlcNAcase (OGA), removes these sugars (Wells et al., 2003). Since
its discovery in 1984, over 800 cellular proteins have been identified as undergoing OGlcNAcylation (Wang et al., 2011). O-GlcNAcylated proteins are abundant in the
nucleus, specifically nuclear pore proteins, but are also ubiquitous in the cytoplasm and
cell membrane. About 25% of the identified O-GlcNAcylated proteins, to date, are
transcription factors or transcription regulatory factors, but many others likely contribute
to cellular signaling, metabolism, and stress response (Hart and Akimoto, 2009). The
abundance of O-GlcNAcylation and its effects on proteins make it highly relevant to
cellular function. Notably, in the absence or hinderance of O-GlcNAcylation, many
proteins often undergo phosphorylation, which drastically alters their activities (Copeland
et al., 2008). The process of O-GlcNAcylation is highly dependent on nutrient
availability, and thus is proposed as a nutrient sensing mechanism that regulates cellular
processes including proliferation, signal transduction, and metabolism as discussed
below.
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Figure 1. Glucose metabolism through the hexosamine biosynthesis pathway
and O-GlcNAcylation.
1.8.1 Manipulation of O-GlcNAcylation
O-GlcNAcylation can be manipulated in cells by controlling glucose
availability, which increases or decreases O-GlcNAcylation of endogenous proteins, or
by altering the activities of the enzymes that metabolize glucose through the HBP.
Alternatively, O-GlcNAcylation can be manipulated directly by controlling the actions of
the OGT and OGA enzymes (Yuzwa et al., 2008; Ortiz-Meoz et al., 2015).
One mechanism to prevent O-GlcNAcylation can be achieved by targeting the
rate limiting enzyme of the HBP, glutamine fructose-6-phosphate aminotransferase
(GFAT). The GFAT enzyme can be targeted with small molecule inhibitors such as 620

Diazo-5-oxo-L-norleucine (DON) and azaserine (Marshall et al., 1991; McClain and
Crook, 1996; Kolm-Litty et al., 1998; Wu et al., 1999). O-GlcNAcylation can also be
impaired by inhibiting OGT, thus preventing the addition of O-GlcNAc sugars to
proteins. OGT is inhibited by the molecules OSMI-1, OSMI-4, and alloxan (Lenzen and
Panten, 1988; Lee et al., 2006; Ortiz-Meoz et al., 2015). Conversely, augmentation of OGlcNAcylation can occur by inhibiting OGA, which otherwise strips the O-GlcNAc
sugars from proteins. The molecules Thiamet-G, streptozotocin (STZ), and PUGNAc
have this inhibitory effect on OGA (Horsch et al., 1991; Kim et al., 2006; Lee et al.,
2006; Yuzwa et al., 2008).
Direct knockout of the OGT and OGA enzymes via genetic manipulation is also
possible, but this usually results in detrimental outcomes. Complete genetic knockout of
OGT, for instance, is embryonic lethal and toxic to cultured cells (Shafi et al., 2000). It
also prevents somatic cell function (O’Donnell et al., 2004). OGA knockout results in
embryonic or neonatal lethality, with detrimental effects that include mitotic defects,
binucleation, chromosome lagging, and growth defects (Yang et al., 2012). Metabolic
deficiencies also occur, including low circulating concentrations of glucose and depleted
storage of liver glycogen (Keembiyehetty et al., 2015). Thus, it is clear that OGlcNAcylation is essential to cellular functions and must be regulated in a homeostatic
manner.
1.8.2 O-GlcNAcylation and Insulin Resistance
Dysregulation of O-GlcNAcylation is associated with many diseases. Hypo-OGlcNAcylation is connected with neurodegenerative diseases including Alzheimer’s,
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Parkinson’s, and Lou Gehrig’s disease (Zachara and Hart, 2004). One of the better
understood connections of O-GlcNAcylation and disease is with diabetes. Increased OGlcNAc in adipocytes and/or muscle cells blocks insulin signaling, leading to insulin
resistance (Ma and Hart, 2013). Overexpression of OGT results in hyper-OGlcNAcylation and a diabetic-like state (Ma and Hart, 2013). As glucose is metabolized
through the HBP, it is first converted to glucosamine, which concomitantly elevates
UDP-GlcNAc availability and increases O-GlcNAcylation. Abnormal increases in OGlcNAcylation, typical of hyperglycemic or hyperinsulinemic states, disturb the balance
between O-GlcNAcylation and O-phosphorylation of cellular proteins (Hart and
Akimoto, 2009). These two processes control cellular signaling, transcription, and other
cellular functions which if left unchecked could lead to glucose toxicity, often associated
with diabetes (Hart and Akimoto, 2009). Hyperinsulinemia can result from hyper-OGlcNAcylation of PDX-1, a protein that controls the transcription of insulin (Fu et al.,
2013). Basically, hyper-O-GlcNAcylation of PDX-1 increases the transcription of the
prohormone insulin (Fu et al., 2013). In the diabetic states, the transcription factor, Sp1,
is also hyper-O-GlcNAcylated, which can either enhance or suppress the transcription of
various genes characteristic of this disease (Hart and Akimoto, 2009). Additionally,
recent evidence suggests that hyper-O-GlcNAcylation of the GLUT4 vesicle protein,
Munc18, inhibits glucose transport in diabetic individuals (Hart and Akimoto, 2009).
1.8.3 O-GlcNAcylation Regulates Cell Proliferation
The effects O-GlcNAcylation on cell proliferation is best understood in cancer
cells. Not only does altering the state of O-GlcNAcylation affect cell proliferation, but
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many of the regulatory molecules that control cell proliferation are in fact modified by OGlcNAc. Some of these proteins include H11, SRC, and proteins of MAPK/ERK
signaling (Dias et al., 2012). Additionally, cell cycle proteins including CDK2, casein
kinase 2 and CLK are modified by O-GlcNAc which inhibit cell cycle progression and
prevent cell proliferation (Hart et al., 2011; Dias et al., 2012). Thus, some degree of OGlcNAcylation is necessary to regulate homeostasis and the proliferative capacity of the
cell. However, extremes of O-GlcNAcylation (e.g., hypo- and hyper-O-GlcNAcylation)
are generally viewed as having a negative impact on cellular functions. For instance,
inhibition of O-GlcNAcylation impairs proliferation of cancer and immortal cells lines
(Jaskiewicz and Townson, 2019; Jaskiewicz et al., 2017; Steenackers et al., 2016; Wang
et al., 2019; Yi et al., 2012). Jiang et al., 2016 showed a direct connection between
manipulated states of O-GlcNAcylation and the mechanisms of concomitant altered cell
proliferation (Jiang et al., 2016). Specifically, they determined that inhibition of OGlcNAcylation, via silencing of OGT, impairs cell viability through downregulation of
cdk-2, cyclin D1 and ERK 1/2 pathways (Jiang et al., 2016). Alternatively, enhancement
of O-GlcNAcylation promotes cell cycle progression and proliferation through the
upregulation of the same pathways(Jiang et al., 2016), and is similar to the rapid cell
proliferation observed in cancer cells (Jiang et al., 2016).
1.8.4 O-GlcNAcylation in Reproductive Tissues
Although study of O-GlcNAcylation in granulosa cells is original, there is
evidence of O-GlcNAcylation in oocytes, cumulus-oocyte-complexes (COC), and sperm
(Dehennaut et al., 2008; Frank et al., 2013, 2014; Li et al., 2018; Sutton-McDowall et al.,
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2006; Tourzani et al., 2018). Direct stimulation of the HBP via glucosamine
supplementation impairs post-compaction embryonic development in bovine and murine
embryos (Schelbach et al., 2010; Sutton-McDowall et al., 2006). Glucosamine
supplementation also decreases oocyte competence through an increase in HSP90
expression (Frank et al., 2014). This result, however, is reversed by the OGT inhibitor,
benzyl 2-acetamido-2-deoxy-α-D-galactopyranoside (BADGP) (Frank et al., 2014).
Complete inhibition of the HBP compromises cumulus expansion (Gutnisky et al., 2007).
O-GlcNAcylation is also essential for the G2/M transition in Xenopus laevis oocytes,
with more than 20 proteins affecting in cell shape and architecture, metabolism, and
translation (Dehennaut et al., 2007, 2008). Enhancement of O-GlcNAcylation has no
known negative effects on oocytes or cumulus cells, but zygote formation is severely
impaired (Zhou et al., 2019). Collectively, these studies illustrate that O-GlcNAcylation
occurs within the oocyte and surrounding cumulus cells and its regulation is important
through specific phases of embryonic development following fertilization.
A connection between O-GlcNAcylation and hormone production is not yet
established, but there is evidence that O-GlcNAcylation affects hormone responsiveness.
For instance, the estrogen receptor (ER) α and β are O-GlcNAcylated (Cheng and Hart,
2000, 2001). For ER α, chemotherapeutics induce O-GlcNAcylation, which in turn
inhibit expression of the receptor on targeted cancer cells (Kanwal et al., 2013).
However, mutation of the O-GlcNAc site of ER β impairs its transcriptional ability,
principally decreasing the stability of the receptor and promoting its degradation. (Cheng
and Hart, 2001; Hart and Sakabe, 2006).
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1.8.5 Glycolysis and O-GlcNAcylation
Enzymes of the glycolytic pathway include aldolase, glyceraldehyde-3-phosphate
dehydrogenase, α-enolase, pyruvate kinase, pyruvate dehydrogenase, and the α and β
chains of lactate dehydrogenase, all of which undergo O-GlcNAc modification
(Dehennaut et al., 2008). Other metabolic enzymes, including creatine kinase,
transketolase, glutathione S-transferase, enolase, phosphofructokinase (PFK) and
adenosylhomo-cysteinase B undergo this modification as well (Dehennaut et al., 2008; Yi
et al., 2012; Champattanachai et al., 2013). For this reason, it is conceivable that nutrient
sensing via O-GlcNAcylation and glucose metabolism through glycolysis, are intimately
linked.
The Warburg Effect is a phenomenon characterized by the metabolic shift from
aerobic glycolysis without completion of oxidative respiration. It is most commonly
observed in rapidly proliferating cancer cells, wherein accelerated conversion of glucose
to lactate occurs (Warburg, 1925). The Warburg Effect is mechanistically linked to OGlcNAcylation because several glycolytic enzymes of the Warburg Effect, including
phosphofructokinase 1, enolase, and other enzymes listed above, are also targets of OGlcNAcylation (Dehennaut et al., 2008; Yi et al., 2012; Champattanachai et al., 2013). OGlcNAcylation of enolase and phosphofructokinase impairs their activity, resulting in
metabolic shifts within the cell (Champattanachai et al., 2013). The observations further
support the idea that O-GlcNAcylation regulates the rate of glycolysis. Further, in 2017,
it was observed that O-GlcNAcylation destabilizes the PKM2 isoform of pyruvate kinase
in a variety of cancer cells (Wang et al., 2017). Pyruvate kinase catalyzes the final step of
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glycolysis to produce pyruvate. O-GlcNAcylation of pyruvate kinase reduces its activity,
which concomitantly increases glucose consumption and lactate output. Hence, OGlcNAcylation of pyruvate kinase promotes the Warburg Effect (Wang et al., 2017). OGlcNAcylation is also associated with abnormal glycolysis in patients with pre-B acute
lymphocytic leukemia (Zhang et al., 2017). Patients that express high blood
concentrations of lactate dehydrogenase, the enzyme required for glycolytic metabolism,
also have higher levels of O-GlcNAcylation, upregulated OGT, and downregulated OGA,
than control patients. These alterations are mediated by the PI3K/ Akt/c-Myc pathway
(Zhang et al., 2017). Knockout of OGT downregulates these glycolytic enzymes and the
extracellular acidification rate (i.e., a measure of glycolytic metabolism and lactate
output), providing a direct connection between O-GlcNAcylation and abnormal
glycolysis in pre-B acute lymphocytic leukemia (Zhang et al., 2017).
1.9 Rationale and Research Objectives
The underlying mechanisms influencing postpartum anestrous in dairy cows are
not fully understood. O-GlcNAcylation is a nutrient sensing mechanism that regulates
cellular processes such as metabolism, proliferation, and survival. O-GlcNAcylation is an
alternate route for glucose metabolism and is reliant on glucose availability in the cell.
Insulin resistance in a phenomenon observed in high producing, postpartum, dairy cows.
Disruption of O-GlcNAcylation might be a mechanism of this insulin resistance.
However, the connections among insulin resistance, glucose availability and OGlcNAcylation in reproductive disorders have not yet been investigated. Although OGlcNAcylation has a large influence on cellular processes, little is known about its effects
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on ovarian physiology, especially in the context of folliculogenesis. Although glucose is
the preferred energy source of granulosa cells, glucose metabolism via the HBP is poorly
understood. The working hypothesis of this study was that O-GlcNAcylation is evident in
bovine granulosa cells and varies between follicle size. Additionally, it was hypothesized
that manipulation of O-GlcNAcylation impairs granulosa cell proliferation. Therefore,
the objectives of the present study were to: 1) Identify and characterize O-GlcNAcylation
in granulosa cells of bovine antral follicles (small and large), and 2), Determine the
importance of O-GlcNAcylation on granulosa cell proliferation.
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CHAPTER 2: EVIDENCE AND MANIPULATION OF O-GLCNACYLATION IN
GRANULOSA CELLS OF BOVINE ANTRAL FOLLICLES
2.1 Introduction
O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a form of posttranslational glycosylation of cellular proteins in which sugar moieties are added to serine
and threonine residues that might otherwise undergo phosphorylation (Comer and Hart,
2000; Bond and Hanover, 2015). The process is highly- conserved and occurs through the
hexosamine biosynthesis pathway (HBP), an alternate path for glucose metabolism in the
cell. As much as 2-5% of all glucose in the cell is metabolized through the HBP. The
enzyme, O-GlcNAc transferase (OGT) adds the GlcNAc sugar from the donor substrate,
UDP-GlcNAc, to proteins. Conversely the enzyme, O-GlcNAcase (OGA), removes these
same GlcNAc sugars from proteins. These two enzymes are the sole enzymatic regulators
of O-GlcNAcylation and work to influence O-GlcNAcylation in a cyclic manner (Bond
and Hanover, 2015). The process of O-GlcNAcylation is highly-dependent on nutrient
availability and is proposed as a nutrient-sensing mechanism within the cell, similar to
the functions of AMP- activated protein kinase(AMPK), insulin/IGF-1 signaling (IIS)
and mammalian target of rapamycin (mTOR) (Hardie et al., 2012; Hardivillé and Hart,
2014; Efeyan et al., 2015). O-GlcNAcylation regulates cellular processes such as
proliferation, signal transduction, and metabolism and is responsive to many aspects of
cellular stress (Hart et al., 2011). For instance, O-GlcNAcylation increases when many
cell types are exposed to heat stress, or hypoxia (Hart et al., 2011). The increase in OGlcNAcylation in response to stress is considered a protective mechanism for cell
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viability (Chatham and Marchase, 2010). Additionally, O-GlcNAcylation modulates cell
signaling, similar to phosphorylation, and kinases can be O-GlcNAcylated (Dias et al.,
2012). Several of these kinases that are subject to either O-GlcNAcylation or
phosphorylation are part of signaling pathways such as MAPK (ERK5, MAPK14,
STK24/25), cell cycle progression (CDK2, casein kinase 2, CLK), cell proliferation
(H11, SRC), cell metabolism (pyruvate kinase, SNARK, protein kinase C), transcription
(BRD3), and cell death (STK24) (Dias et al., 2012).
Several nutrient sensing pathways that impact granulosa cell (GC) function and
folliculogenesis include AMPK, IIS, and mTOR. Activation of AMPK hinders FSH and
IGF-1 induced GC proliferation, and impairs progesterone and estradiol secretion.
(Kayampilly & Menon, 2009; Tosca et al., 2006; Tosca et al., 2005, 2010). Stimulation
of insulin signaling supports granulosa cell proliferation and FSH induced estradiol
secretion (Campbell et al., 1995). Lastly, inhibition of mTOR reduces GC proliferation
and impedes follicle growth in vitro (Yaba et al., 2008). Although O-GlcNAcylation
influences cellular processes, there is little known about its role in ovarian physiology,
folliculogenesis, or for that matter, GC metabolism. Glucose is the preferred energy
substrate of GCs, but glucose metabolism in the growing follicles remains poorly
understood, especially as it pertains to the HBP and alternate pathways of glucose
utilization. The possibility exists that the HBP in conjunction with O-GlcNAcylation
controls many cellular processes of GCs, including metabolism and proliferation, which
are critical for follicular development, but these concepts have not been experimentally
tested.
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In this study, glucose metabolism in the GCs of bovine ovarian follicles was
evaluated in context of the HBP. Our objectives were to assess O-GlcNAcylation in
bovine GCs of antral follicles of different sizes (i.e., small and large), and evaluate the
effects of O-GlcNAcylation on GC function. It was hypothesized that O-GlcNAcylation
in GCs differs between follicle size and impacts GC proliferation. This study is the first
to report the presence of O-GlcNAcylation in GCs of bovine antral follicles, and its
positive impact of GC proliferation.
2.2 Materials and Methods
2.2.1 Granulosa Cell Isolation and Follicular Fluid Collection
Pairs of bovine ovaries were collected from an abattoir (Champlain Beef, Whitehall, NY)
and transported to the laboratory in 0.9% sterile saline with antibiotic-antimycotic
(10,000 units/mL of penicillin, 10,000 µg/mL of streptomycin, and 25 µg/mL of Gibco
Amphotericin B) (Gibco, Gaithersburg, MD) at room temperature for processing within
4-6 hours of slaughter. The ovaries were morphologically staged to the estrous cycle
based upon the visual appearance of the corpus luteum (Ireland et al., 1980). Only ovaries
within the mid-to-late estrous cycle, were used. Small antral follicles (3-5 mm) (12-24
follicles per ovary pair) were aspirated with a 21-gauge needle and 3mL luer lock syringe
and the granulosa cells (GCs) were pooled into a single sample. Large antral follicles
(>10 mm) were dissected from the ovary and aspirated to obtain GCs. Only the largest
follicle from each ovary pair was aspirated for collection. After aspiration of the large
follicles, the follicles were then sliced and scraped with a 5mm rubber policeman. All
samples were centrifuged at 84 x g for 10 minutes at 4◦C to separate GCs from the
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follicular fluid. The follicular fluid was separated, aliquoted, and frozen at -80◦C until
further analyses were performed. The cell pellets were resuspended in 1X Red Blood Cell
Lysis Buffer (#5831, Biovision, Milpitas, CA) and centrifuged for 5 minutes at 84 x g to
eliminate red blood cells (RBC).
2.2.2 Granulosa Cell Lysis
After RBC lysis, GCs were resuspended in PBS in preparation for lysis. Suspensions
were centrifuged at 2655 x g for 10 minutes at 4◦ C and the PBS wash was repeated. PBS
was removed, and the cells were resuspended in RIPA lysis buffer (20 mM Tris HCl, 150
mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% TritonX 100) with HALT
protease/phosphatase inhibitor (Thermo Scientific, Waltham, MA) for 10 minutes. Each
suspension was further lysed via aspiration with a 27-gauge needle (BD, Franklin Lakes,
NJ). Samples were vortexed for 15 seconds and centrifuged at 15,294 x g for 10 minutes.
The supernatant was removed, diluted in Lamelli sample buffer and boiled at 100◦ C for
1-3 minutes. Initial protein quantification and standardization was not performed because
of limited sample abundance. Instead, samples were normalized to the total protein
present within the gels prior to transfer by densitometric analyses.
2.2.3 Immunoblotting
Lysates of GCs from small and large follicles were used. Protein extracts were separated
on precast, stain free 10% gels (BioRad, Hercules, CA). Following electrophoretic
separation, gels were activated and imaged for total protein on the BioRad ChemiDoc
Imaging System. Proteins were transferred to a PVDF membrane (BioRad) using a semidry transfer system at 45mA for 1 hour (Hoefer, Holliston, MA). Post transfer, the gels
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were again imaged on the ChemiDoc Imaging System (BioRad) to ensure complete
transfer of separated proteins. Following protein transfer, the PVDF membranes were
blocked in Tris-buffered saline (TBS) blocking buffer containing 5% BSA and
0.2%Tween 20 (TBST; Fisher Bioreagents, Pittsburgh, PA) for 3 hours on a platform
rocker at room temperature. Membranes were incubated overnight at 4◦ C with mouse
anti-O-GlcNAc (1:2500, CTD 110.6) or rabbit anti-OGT (1:1000, D1D8Q) primary
antibodies, both from Cell Signaling Technology (Danvers, MA). Following overnight
incubation, membranes were washed with TBST under agitation in the following order:
2X 10-30 seconds, 1X for 15-minutes and 3X for 5-minutes. The membranes were then
incubated in secondary antibody for 1 hour on a platform rocker at room temperature.
Goat-anti-mouse (1:5000) and goat-anti-rabbit (1:5000) horseradish peroxidase (HRP)
conjugated secondary antibodies from Santa Cruz Biotechnologies (Dallas, TX)
respectively, were used. The membranes were washed as described above and were then
incubated in Clarity Western ECL Blotting substrate (BioRad) for 5 minutes.
Immunodetectable proteins were imaged on the ChemiDoc Imaging System (BioRad).
After imaging, the membranes were stripped using Restore Western Blot Stripping Buffer
(Thermo Scientific) per manufacturer’s instructions and reprobed for OGT using the
methods described above. However, the membranes were placed in blocking buffer for 3
hours at room temperature prior to re-probing. O-GlcNAc and OGT protein values were
normalized to total protein within the gels prior to immunoblotting. Images were
analyzed using Image J (National Institute of Health) for protein quantification.
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2.2.4 Granulosa Cell Culture
Bovine GCs were collected as described above and seeded into T25 flasks (Corning,
Tewksbury, MA) in 1:1 DMEM/F12 (Gibco) + 10% fetal bovine serum (Corning) media
with the addition of an antibiotic-antimycotic regimen (10,000 units/mL of penicillin,
10,000 µg/mL of streptomycin, and 25 µg/mL of Gibco Amphotericin B) (Gibco). Cells
were grown for 72 hours, transitioned to serum-free DMEM/F12 media containing
insulin (100ng/mL)-transferrin (55ng/mL)-selenium (6.7pg/mL) (ITS) and were treated
with the GFAT inhibitor, DON (50 µM), the OGA inhibitor, Thiamet-G (2.5 µM), or the
OGT inhibitor, OSMI-1 50 μM based upon previously published studies (Ortiz-Meoz et
al., 2015; Jaskiewicz et al., 2017). All inhibitors were sourced from Cayman Chemical
(Ann Arbor, MI), and were used for a period of 4-24 hours. As Thiamet-G and OSMIwere reconstituted in dimethyl sulfoxide (DMSO) (Fisher Scientific), at 1000X, control
cultures of GCs were also spiked with 0.1% DMSO. Following treatment, flasks were
placed on ice and washed three times with 1 mL PBS prior to GC lysis by RIPA buffer.
Next, PBS was removed and 200-500 µL of RIPA lysis buffer was added for 10 minutes.
Flasks were then scraped with a cell scraper to remove the GCs from the bottom of the
flasks. The GCs were collected into 1.5mL microcentrifuge tubes and further lysed by
aspirating through a 27-gauge needle (BD). Samples were vortexed for 15 seconds and
centrifuged at 15,294 x g for 10 minutes. The supernatant was removed, and protein was
standardized using a bicinchoninic acid (BCA) colorimetric assay (Thermo Scientific)
following manufacturer’s instructions. Absorbance at 562 nm was measured by the
Synergy HT Plate Reader (Biotek, Winooski, VT). Lysates were diluted in RIPA buffer
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and Lamelli sample buffer and boiled at 100◦ C for 1-3 minutes. Electrophoresis and
immunoblotting of proteins from cultured cell lysates were conducted essentially as
described above. In this instance, however, protein was quantified using BCA assay and
10 ng of protein was loaded into each well (25 μL total volume loaded per well).
Immunoblotting and densitometric analyses were performed as described above and
performed in triplicate.
2.2.5 Metabolite Assays
Samples of follicular fluid from the small and large antral follicles used for
immunoblotting were assayed for concentrations of glucose and lactate. Commerciallyavailable colorimetric kits were used for measuring glucose (Sigma, St. Louis, MO,
MAK263) and lactate (Sigma, MAK064) following manufacturer’s instructions,
including the development of a standard curve. For the lactate assay, a serial dilution of
the follicular fluid collected from small follicles in the provided assay buffer (1:100), was
necessary because of the high concentration of lactate present in neat samples.
Absorbance at 570 nm was measured by the Synergy HT Plate Reader (Biotek) for both
glucose and lactate assays.
2.2.6 Steroid Assays
Samples of follicular fluid from the small and large antral follicles were assayed for
concentrations of estradiol and progesterone. Radioimmunoassays were performed in the
laboratory of Dr. George Perry, South Dakota State University using methods described
previously (Perry and Perry, 2008). Serial dilutions (1:10-1:100,000) of samples were
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performed using 1% BSA. The intra-assay coefficients of variation were 3.84 ng/mL and
4.39 ng/mL for the estradiol and progesterone assays, respectively.
2.2.7 Granulosa Cell Proliferation Assays
GCs of small and large antral follicles were aspirated from ovarian pairs as described
above. The GCs were combined into separate pools each for small and large follicles. The
GCs were counted and assessed for viability using the TC20 Automated Cell Counter
(BioRad) and Trypan Blue (GE Healthcare, Marlborough, MA) exclusion staining,
respectively. Viability for the small follicle pools averaged 20% and for the large pools
averaged 15%. Cells were seeded in 1:1 DMEM/F12 (Gibco) + 10% fetal bovine serum
(Corning) media with the addition of an antibiotic-antimycotic regimen (10,000 units/mL
of penicillin, 10,000 µg/mL of streptomycin, and 25 µg/mL of Gibco Amphotericin B)
(Gibco) at 5,000 viable cells/well into 96 well plates (Costar, Tewksbury, MA) to attach
and grow for 36 hours. The GCs were then transitioned to serum-free DMEM/F12 media
containing insulin (100ng/mL)-transferrin (55ng/mL)-selenium (6.7pg/mL) (ITS), and
were treated with the GFAT inhibitor, DON (50 µM), the OGT inhibitor, OSMI-1 (50
µM), or the OGA inhibitor, Thiamet-G (2.5 µM), similar to the cell culture protocol
described above. After 24 hours of treatment, GC proliferation was measured using the
CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) kit following
manufacturer instructions (Promega, Madison, WI) including the use of a Synergy HT
Plate Reader (BioTek). Proliferation was measured 4 hours after the addition of the MTS
Reagent.
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2.2.8 Granulosa Cell Proliferation (Ki-67immunodetection)
GCs from small and large antral follicles were aspirated and pooled from ovarian pairs as
described above. Following isolation, the GCs were seeded onto coverslips in 12 well
plates at a density of 50,000 viable cells/well and allowed to grow for 36 hours. The cells
were then exposed to Thiamet-G (2.5 µM) or OSMI-1 50 (µM) for 24 hours. Following
treatment, the cells were washed with PBS + 0.1% BSA (Fisher Bioreagents) and then
fixed with 10 mL of 100% ice-cold methanol (Fisher Scientific) and incubated at -20◦ C
for 10 minutes. Fixative was removed, and the cells were washed three times with 1X
PBS + 0.1% BSA. Subsequently, the coverslips with attached cells were removed from
the plates and placed cell side down on blocking buffer, 10% normal goat serum (Vector
Laboratories, Burlingame, CA) + 1X PBS +0.1%BSA, in an incubation chamber for 1
hour. They were then incubated with rabbit anti-Ki-67 monoclonal antibody (1:200,
MA5-14520, Invitrogen, Carlsbad, CA) overnight at 4◦ C. The coverslips were then
washed as described above and incubated in goat anti-rabbit (1:100, Santa Cruz
Biotechnology) secondary antibody for 1 hour in the dark. After washing, the coverslips
were incubated in ImmPACT DAB (Vector) for 10 minutes in the dark. The coverslips
were then rinsed in cold tap water, Scott’s Tap Water Solution for 1 minute, and again in
cold tap water. The GCs were then counterstained with hematoxylin (Vector) and washed
with distilled water until clear. The coverslips were mounted using VectaMount AQ
(Vector) and allowed to dry for 24 hours prior to imaging. Slides were viewed and
imaged using an Invitrogen EVOS M5000 microscope (Thermo Fisher, Carlsbad, CA).
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Image analysis was conducted using the Cell Counter function on ImageJ (National
Institute of Health).
2.2.9 Statistics
A paired t-test was used to compare O-GlcNAc and OGT expression between GCs
obtained from small and large follicles within the same ovary pair. Similarly, a paired ttest was used to test for differences in glycolytic components and steroids in the follicular
fluid between small and large follicles of the same ovary pair. A repeated measures oneway ANOVA followed by Dunnett’s multiple comparisons or a paired t test were used to
evaluate O-GlcNAcylation and cell proliferation relative to treatment. Ki-67 expression
was analyzed with a Friedman test followed by Dunn’s multiple comparisons. Significant
differences were declared as P<0.05. Asterisks denote differences between small and
large follicles or from control. Different letters denote differences among treatments.
Tests were performed using GraphPad Prism 8 statistical software.
2.3 Results
2.3.1 Glucose and lactate concentrations in follicular fluid differ by follicle size
Analyses of the follicular fluid of small and large follicles within the same ovary pair
indicated differences in glucose (P<0.05) and lactate (P<0.05). As shown in Figure 1,
large follicles had higher glucose concentrations (P<0.05), but lower lactate
concentrations (P<0.05) than small follicles. Notably, even though overall lactate
concentrations were lower in large follicles than small, on a per millimolar basis the
amount of lactate in the follicular fluid remained greater than that of glucose.
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Figure 1. Relative concentrations of glucose and lactate in follicular fluid of bovine
follicles according to follicle size. (A) Glucose concentrations and (B) lactate
concentrations are depicted for small (SF; 3-5mm) and large (LF; >10mm) bovine
follicles. Results represent n=7 ovary pairs, run in duplicate, with the mean +/- SEM
concentration (mM) of a given metabolite shown. Asterisks denote differences
between SF and LF at P<0.05.

2.3.2 Both small and large follicles have high P4:E2 ratios
In all 7 small follicles analyzed, the concentration of progesterone (P4) to estradiol (E2)
had a ratio of greater than 10. Similarly, 5 of the 7 pools of large follicles had a P4/E2
ratio greater than 10 and 2/7 had intermediate ratios of >1<10. All 7 ovary pairs were
used in further analyses. The average E2 concentration of small follicles was 1.60 ng/mL,
with a range of 0.10- 6.34 ng/mL. The average E2 concentration of large follicles was
13.4 ng/mL, with a range of 0.199-55.9 ng/mL. E2 concentrations did not differ between
small and large follicles (P>0.05, n=7). Conversely, the average P4 concentration of
small follicles was 130.5 ng/mL, with a range of 38.5-470.9 ng/mL. The average P4
concentration of large follicles was 157 ng/mL, with a range of 19.8-377 ng/mL. P4
concentrations did not differ between follicle size (P>0.05, n=7).
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2.3.3 Global O-GlcNAcylation and OGT expression of bovine granulosa cells varies
with follicle size
Immunoblotting revealed a difference in the expression of global O-GlcNAcylation
(P<0.05) and OGT (P<0.05) in GCs of small versus large antral follicles within the same
ovary pair. As shown in Figure 2, GCs obtained from small follicles had greater
expression of global O-GlcNAcylation (P<0.05) and OGT (P<0.05) than GCs of large
follicles.

Figure 2. Detection of O-GlcNAcylation and OGT protein expression of fresh bovine
granulosa cells. (A) Immunoblot of global O-GlcNAcylation and OGT (110 kDa)
expression of bovine granulosa cells of small (SF) and large (LF) follicles. (B)
Densitometric analysis of O-GlcNAcylated proteins and OGT expression in bovine
granulosa cells relative to total protein. Results represent n=7 ovary pairs run in
triplicate, with the mean +/- SEM signal intensity shown. Asterisks denote
differences between SF and LF at P<0.05.
2.3.4 Disruption of O-GlcNAcylation impairs granulosa cell proliferation
As shown in Figure 3, the GFAT inhibitor DON (50µM), impaired O-GlcNAcylation in
GCs from small (P<0.05, n=5 expts.) and large follicles (P<0.05, n=5 expts.) and
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impaired GC proliferation regardless of follicle size (P<0.05, n=4 expts.). As shown in
Figure 4, a time-course experiment of OSMI-1 revealed that OSMI-1 impairs OGlcNAcylation in GCs from small follicles at 4- and 8-hours post treatment (P<0.05, n=3
expts.), but not at 12 or 24 hours (P>0.05, n=3 expts.). In GCs of large follicles, OSMI-1
had no effect on O-GlcNAcylation regardless of length of treatment (P>0.05, n=3 expts.).
OSMI-1 (50µM) similarly impaired GC proliferation of small follicles (P<0.05, n=6
expts.) with no effect on GC proliferation of large follicles. As shown in Figure 5,
inhibition of OGA, via Thiamet- G (2.5 µM) augmented O-GlcNAcylation in GCs
regardless of follicle size (P<0.05, n=3 expts.) but had no effect on GC proliferation,
regardless of follicle size (P>0.05, n=6 expts.). As shown in Figure 6, inhibition of OGlcNAcylation in GCs of small follicles resulted in a smaller percentage of ki-67 positive
cells compared to control or GCs exposed to Thiamet-G (P<0.05, n=5 expts.). No
differences in the percentage of ki-67 positive cells were observed in the GCs obtained
from large follicles, regardless of O-GlcNAcylation status (P>0.05, n=6 expts).
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Figure 3. DON impairs O-GlcNAcylation and cell proliferation in cultured bovine
granulosa cells. (A) Immunoblot and densitometric analyses of global OGlcNAcylation expression of bovine granulosa cells of small follicles treated with
DON (50 µM) for 24 hours. (B) Proliferation of granulosa cells from small follicles
as measured by absorbance using an MTS assay. (C) Immunoblot and densitometric
analyses of global O-GlcNAcylation expression of bovine granulosa cells of large
follicles treated with DON (50 µM) for 24 hours. (D) Proliferation of granulosa cells
from large follicles as measured by absorbance using an MTS assay. Results
represent n=5 (immunoblot) or n=4 (MTS) independent experiments run in
triplicate, with the mean +/- SEM signal intensity shown or absorbance at 490 nm
shown. Asterisks denote differences from control at P<0.05.
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Figure 4. OSMI-1 impairs granulosa cell proliferation and O-GlcNAcylation of
cultured bovine granulosa cells in a time-dependent manner. (A) Immunoblot and
densitometric analyses of global O-GlcNAcylation expression of bovine granulosa
cells of small follicles treated with OSMI-1(50 µM) for 4, 8, 12, or 12 hours. (B)
Proliferation of granulosa cells from small follicles as measured by absorbance
using an MTS assay. (C) Immunoblot and densitometric analyses of global OGlcNAcylation expression of bovine granulosa cells of large follicles treated with
OSMI-1(50 µM) for 4, 8, 12, or 24 hours. (D) Proliferation of granulosa cells from
large follicles as measured by absorbance using an MTS assay. Results represent
n=3 (immunoblot) or n=6 (MTS) independent experiments run in triplicate, with the
mean +/- SEM signal intensity shown or absorbance at 490 nm shown. Asterisks
denote differences from control at P<0.05.
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Figure 5. Thiamet-G augments O-GlcNAcylation of cultured bovine granulosa cells.
(A) Immunoblot and densitometric analyses of global O-GlcNAcylation expression
of bovine granulosa cells of small follicles treated with Thiamet-G (2.5 µM) for 24
hours. (B) Proliferation of granulosa cells from small follicles as measured by
absorbance using an MTS assay. (C) Immunoblot and densitometric analyses of
global O-GlcNAcylation expression of bovine granulosa cells of large follicles
treated with Thiamet-G (2.5 µM) for 24 hours. (D) Proliferation of granulosa cells
from large follicles as measured by absorbance using an MTS assay. Results
represent n=3 (immunoblot) or n=6 (MTS) independent experiments run in
triplicate, with the mean +/- SEM signal intensity shown or absorbance at 490 nm
shown. Asterisks denote differences from control at P<0.05.
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Figure 6. Immunodetection of granulosa cell proliferation (via Ki-67 staining)
following augmentation or inhibition of O-GlcNAcylation via Thiamet-G (2.5 µM)
or OSMI-1 (50 µM) for 24 hours, respectively. The percentage of Ki-67 positive cells
from small (A) or large (B) follicles is shown. (C) Photomicrographs of ki-67 positive
cells from small (SF) or large (LF) follicles following treatment at 20x magnification.
Results represent n=5 experiments, run in duplicate, with the mean +/- SEM of ki67
expression shown. Different letters denote differences among treatments at P<0.05.

2.4 Discussion
In this study, glucose metabolism in bovine granulosa cells resulting in OGlcNAcylation was evaluated. We present clear evidence that not only do bovine GCs
readily express O-GlcNAcylated proteins, but that O-GlcNAcylation occurs through the
HBP and is a result of the enzymatic actions of GFAT, OGT, and OGA. Here, follicle
health status was assessed by P4:E2 ratios of the follicles. A broad range of P4 ((38.5470.9 ng/mL) and (19.8-377 ng/mL)) and E2 ((0.10- 6.34 ng/mL) and (0.1955.99ng/mL)) concentrations were observed across follicles of different animals and
between follicle sizes. Grimes and coworkers classified follicles on histological and nonhistological characteristics (i.e., steroid profiles) to determine their health status as being
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non-atretic or undergoing a classified level of atresia (Grimes et al., 1987). All 7 of the
small follicles had an P4:E2 ratio >10 indicating highly atretic follicles. Similarly, 5 of
the 7 large follicles were categorized as highly atretic and 2 of the follicles were
classified as intermediately atretic with a P4:E2 ratio >1 but <10. Although the samples
varied in their level of atresia, the follicular fluid and GCs showed no differences in the
subsequently assessed parameters (i.e., glucose, lactate, O-GlcNAcylation) and all 7
ovary pairs were analyzed.
Global O-GlcNAcylation was evident in both small and large antral follicles, but
with a greater degree of O-GlcNAcylation detectable in GCs from small follicles.
Interestingly, small follicles also contained less glucose in the follicular fluid, potentially
suggesting that a greater proportion of glucose is metabolized by the GCs of these
follicles, which can then be shunted toward the HBP. Rapid glucose metabolism is often
indicative of glycolytic processes, rather than oxidative phosphorylation (Nandi et al.,
2008), and this concept is supported in the current study by the observation that the small
antral follicles also contained very high concentrations of lactate, a product of glycolytic
metabolism. Similar findings were also found in other species. For instance, in sheep,
glucose metabolized to lactate (i.e., glycolytic metabolism) is the preferred pathway for
gonadotropin-induced differentiation of the GCs (Campbell et al., 2010). Similarly, in
pigs, GCs of small antral follicles undergo rapid cell proliferation, which is accompanied
by a metabolic shift from aerobic glycolysis without completion of respiration, known as
the Warburg Effect (Costermans et al., 2019). The Warburg Effect is characteristic of
rapidly proliferating cancer cells, wherein accelerated conversion of glucose to lactate
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results (Warburg, 1925). The Warburg Effect is also mechanistically linked to OGlcNAcylation because several glycolytic enzymes of the Warburg Effect including
phosphofructokinase 1 and enolase are targets of O-GlcNAcylation (Yi et al., 2012;
Champattanachai et al., 2013). O-GlcNAcylation of these enzymes impairs their activity,
potentially influencing metabolic shifts within the cell (Champattanachai et al., 2013).
Thus, the O-GlcNAcylation has a role in regulating the rate of glycolysis.
In the current study, as follicle size increased, glucose concentrations
accumulating within the follicular fluid also increased. Conversely, lactate concentrations
decreased. The concentrations here are similar to what others observed (Leroy et al.,
2004b; Nandi et al., 2008). These observations are consistent with the current thinking
about the prevailing form of metabolism occurring within bovine antral follicles as they
grow during folliculogenesis (Leroy et al., 2004b; Orsi et al., 2005b; Nandi et al., 2007).
Specifically, these authors suggest that the relative concentrations of glucose and lactate
concentrations are attributed to the enhanced glucose uptake and glycolytic metabolism
within small follicles, that diminishes as the follicles increase in size and maturity (Leroy
et al., 2004b; Orsi et al., 2005b). An alternative explanation is that as follicles grow, the
permeability of the blood-follicle barrier increases, which could alter metabolite
concentrations to be more similar to that of the blood serum at that point in time
(Edwards, 1972; Bagavandoss et al., 1983). Our results are consistent with the concept
that GCs of small follicles exhibit the glycolytic metabolism (i.e., the Warburg Effect),
conducive to rapid cell proliferation. Enhanced glucose uptake and glycolytic metabolism
are also consistent with the greater extent of O-GlcNAcylation observed in the GCs of
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small follicles, presumably as they shunt excess glucose to the HBP. Conversely, the
increase in glucose accumulation in the follicular fluid of large follicles, accompanied by
less lactate, suggests that GCs in these follicles metabolically transition to oxidative
phosphorylation, wherein glucose becomes completely oxidized. Indeed, the observation
of diminished O-GlcNAcylation in the GCs of large follicles hints that there is less
glucose available to shunt to the HBP. Collectively, the above observations offer a
scenario in which glycolytic metabolism and O-GlcNAcylation could favor GC
proliferation (small antral follicles); whereas oxidative phosphorylation and diminished
O-GlcNAcylation support GC function and differentiation (large antral follicles). Initial
evidence in support of this scenario is presented here, in that inhibiting O-GlcNAcylation
(via DON or OSMI-1) always impaired proliferation of GCs from small antral follicles.
The concept that glucose metabolism and O-GlcNAcylation influence cell
function is borne out by experiments in the current investigation in which disrupting
either the HBP or endogenous O-GlcNAc cycling affected GC proliferation. At the rate
limiting step of glucose processing through the HBP, inhibiting GFAT (via DON),
prevented the synthesis of all downstream intermediates, including the formation of
UDP-GlcNAc for O-GlcNAcylation, and inhibited cell proliferation of GCs from both
small and large antral follicles. These results were expected as hypo-O-GlcNAcylation
impairs proliferation of the most rapidly dividing cells, including cancer cells and other
immortal cell lines (Steenackers et al., 2016; Jaskiewicz et al., 2017). However, when
inhibition of O-GlcNAcylation occurred more directly, via the OGT inhibitor, OSMI-1,
only the proliferation of GCs from small follicles was noticeably compromised. We
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interpret this outcome as being a consequence of the GCs of small follicles having greater
capacity to divide than GCs of large follicles. This thinking is also consistent with the
GCs having a prominent role in the ability of the follicle to grow during folliculogenesis.
Conversely, GCs of large follicles are presumed to be nearing the stages of terminal
differentiation or luteinization, wherein cell division is less frequent (Ali et al., 2001;
Girard et al., 2015), acquisition of LH receptors occurs (Ireland and Roche, 1983;
Bodensteiner et al., 1996; Ginther et al., 1999), and resistance to apoptosis becomes
attainable (Jolly et al., 1994). Indeed, under culture conditions, we and others have found
that GCs typically obtained from small antral follicles exhibit greater rates of
proliferation, with a shorter generation interval, than GCs obtained from larger follicles
(Costermans et al., 2019, unpublished observations). In the current study, GC
proliferation was measured by both mitochondrial activity (MTS assay) and the cell
proliferation marker, ki-67 (immunodetection), which is only expressed by dividing cells.
The lack of O-GlcNAcylation (via DON and OSMI-1 treatment) prevented cell
proliferation by both impeding aspects mitochondrial activity and disrupting the cell
cycle.
Enhanced O-GlcNAcylation, or hyper-O-GlcNAcylation is associated with
augmented cell proliferation and enhanced tumorigenic potential (Liu et al., 2016;
Jaskiewicz and Townson, 2019). Specifically, hyper-O-GlcNAcylation enhances cancer
cell aggressiveness through increased expression of epithelial-mesenchymal transition
genes, stimulating cell proliferation, and enhancing cell migration and/or invasiveness. In
contrast, hypo-O-GlcNAcylation impairs proliferation and these very same measures in
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endometrial cancer cells (Jaskiewicz and Townson, 2019). Additional evidence
supporting the idea that some degree of O-GlcNAcylation is required for cell homeostasis
comes from genetic knockout experiments, in which knockout of the OGT enzyme is
embryonic lethal in mice as well as in embryonic stem cells (Shafi et al., 2000).
Conversely, OGA knockouts are less phenotypically severe: there is lethality in the
neonatal mouse and the detrimental effects include growth defects, mitotic defects,
binucleation, and chromosome lagging (Yang et al., 2012). In the current study,
augmentation of O-GlcNAcylation (via Thiamet-G) had no effect on GC proliferation
from either small or large antral follicles. It is conceivable that GCs from small follicles
are already metabolizing glucose and proliferating at such rapid rates, that further
stimulation of these activities is unattainable experimentally. On the other hand, GCs
from large follicles perhaps have become committed to their terminal fate (i.e., apoptosis,
luteinization), and thus are resistant to alterations of glucose metabolism involving the
HBP. These issues merit further investigation.
The current study is the first to detect and characterize O-GlcNAcylation in GCs
of bovine antral follicles, but others have recently reported the existence of OGT, OGA,
and O-GlcNAcylated proteins in bovine cumulus oocyte complexes (COCs) (Zhou et al.,
2019). Hyper-O-GlcNAcylation (via Thiamet-G), had no detrimental effects on the
cumulus cells or the oocyte, but, zygote formation following in vitro fertilization was
compromised (Zhou et al., 2019). Other investigations indicate, however, that increased
glucose shunting through the HBP, thus potentiating O-GlcNAcylation, does have
deleterious effects on oocyte health and developmental competence. For instance,
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glucosamine is a direct substrate for the HBP and O-GlcNAcylation and perturbs postcompaction bovine and murine embryo development (Sutton-Mcdowall et al., 2006;
Schelbach et al., 2010). Inhibiting O-GlcNAcylation via the alternative OGT inhibitor,
BADGP, reverses these detrimental effects (Sutton-Mcdowall et al., 2006).
Supplementation of glucosamine to mouse COCs also increases HSP90 expression, an
effect reversed by using BADGP and is associated with decreased oocyte competence.
(Frank et al., 2014). Complete inhibition of the HBP and O-GlcNAcylation via DON,
however, prevents cumulus expansion (Gutnisky et al., 2007). Collectively, these
observations suggest that O-GlcNAcylation is essential to some of the major constituents
of the growing follicle (i.e., granulosa cells, cumulus cells, and oocyte), and helps support
their growth, health, and developmental competence in a homeostatic manner.
There is growing evidence to speculate that O-GlcNAcylation exerts direct effects
within reproductive tissues through classical signaling pathways. For instance, estrogen
receptors α and β of Sf 9 cells are heavily O-GlcNAcylated (Cheng and Hart, 2000,
2001). Cancer treatments inducing O-GlcNAcylation in MCF-7 cells, inhibit ER α
expression (Kanwal et al., 2013). In contrast, O-GlcNAcylation of the ER β prevents its
degradation and modulates its stability (Cheng and Hart, 2001). Mutation of the OGlcNAc site of ER β negatively impacts its transcriptional ability, thus, O-GlcNAcylation
of the receptor may serve as a protective mechanism (Cheng and Hart, 2001; Hart and
Sakabe, 2006). Although somewhat limited in scope at this point, these studies provide
credibility to the thought that O-GlcNAcylation may also modulate the direct actions of
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steroids on ovarian function, including folliculogenesis and oocyte maturation, through
their influence on receptor-mediated effects.
2.5 Conclusion
In conclusion, the mechanism(s) by which O-GlcNAcylation influences granulosa
cell proliferation and potentially impacts overall granulosa cell function in bovine antral
follicles is not understood at the current time and offers fertile ground for further
investigations. Our studies indicate that the relative differences in glucose and lactate
accumulation within the follicular fluid as follicles grow mirrored by the relative state of
O-GlcNAcylation within the granulosa cells. Granulosa cells of small follicles exhibit
greater expression of O-GlcNAcylation than those of large follicles, possibly because
glucose is more readily metabolized glycolytically to support cell proliferation. As
downregulation of O-GlcNAcylation inhibits granulosa cell proliferation, we suggest that
this might be important as follicles mature and granulosa cells prepare to differentiate
(e.g., luteinization). Further studies should focus on determining the identity of key OGlcNAcylated proteins in the follicle, the effects of O-GlcNAcylation on steroidogenesis
and steroid action, and the role of O-GlcNAcylation as a potential nutrient sensor in
folliculogenesis.
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CHAPTER 3: EXPLORATORY EXPERIMENTS
3.1 Dose Response Experiments and Granulosa Cell Proliferation
3.1.1 Abstract
O-GlcNAcylation is directly regulated by two enzymes, OGT and OGA. OGT
adds GlcNAc sugars onto serine or threonine residues of proteins. Conversely, OGA
removes these GlcNAc sugars from proteins. The two enzymes work together in a cyclic
manner, similar to that observed in phosphorylation and dephosphorylation, respectively.
Small molecule inhibitors of OGT and OGA are commercially available and effectively
augment or impair O-GlcNAcylation. Thiamet-G, an OGA inhibitor, augments OGlcNAcylation, whereas OSMI-1, an OGT inhibitor, inhibits this process. Effective
concentrations of these inhibitors vary among cell type as evidenced by the scientific
literature (Ortiz-Meoz et al., 2015; Jaskiewicz et al., 2017; Jaskiewicz and Townson,
2019). Here, dose response experiments were conducted to determine the optimal
working concentrations of these inhibitors for treating bovine granulosa cells (GC).
Bovine ovary pairs morphologically staged to the mid-to-late estrous period were used
(Ireland et al., 1980). GCs were aspirated from small (3-5mm) and large (>10mm)
follicles. GCs were seeded into 96 well plates and treated with either Thiamet-G (1, 2.5,
or 5 µM) or OSMI-1 (25 or 50 µM). After 24 hours, proliferation was measured with
MTS assay. No concentration of Thiamet-G affected GC proliferation in either size of
follicles (P>0.05, n=6 expts.). OSMI-1 impaired GC proliferation at both concentrations
for GCs of small follicles (P<0.05, n=6 expts.), but had no effect on GC proliferation for
large follicles (P>0.05, n=6 expts.).
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3.1.2 Materials and Methods
3.1.2.1 Granulosa Cell Isolation
Pairs of bovine ovaries were collected from an abattoir (Champlain Beef, Whitehall, NY)
and transported to the laboratory in 0.9% sterile saline with antibiotic-antimycotic
(10,000 units/mL of penicillin, 10,000 µg/mL of streptomycin, and 25 µg/mL of Gibco
Amphotericin B) (Gibco, Gaithersburg, MD) at room temperature for processing within
4-6 hours of slaughter. The ovaries were morphologically staged to the estrous cycle
based upon the visual appearance of the corpus luteum (Ireland et al., 1980). Only ovaries
within the mid-to-late estrous cycle, were used. Small antral follicles (3-5 mm) (12-24
follicles per ovary pair) were aspirated with a 21-gauge needle and 3mL luer lock syringe
(BD) and the granulosa cells (GCs) were pooled into a single sample. Large antral
follicles (>10 mm) were dissected from the ovary and aspirated to obtain GCs. Only the
largest follicle from each ovary pair was aspirated for collection. After aspiration of the
large follicles, the follicles were then sliced and scraped with a 5 mm rubber policeman.
All samples were centrifuged at 84 x g for 10 minutes at 4◦C to separate GCs from the
follicular fluid.
3.1.2.2 Granulosa Cell Proliferation Assay
Bovine GCs were collected as described above and seeded at 5000 viable cells/well into
96 well plates (Corning, Tewksbury, MA) in 1:1 DMEM/F12 (Gibco) + 10% fetal bovine
serum (Corning) media with the addition of an antibiotic-antimycotic regimen (10,000
units/mL of penicillin, 10,000 µg/mL of streptomycin, and 25 µg/mL of Gibco
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Amphotericin B) (Gibco). Cells were grown for 36 hours, transitioned to serum-free
DMEM/F12 media containing insulin (100ng/mL)-transferrin (55ng/mL)-selenium
(6.7pg/mL) (ITS) and were treated with the OGT inhibitor, OSMI-1 (25 or 50 µM), the
OGA inhibitor, Thiamet-G (1, 2.5, or 5 µM) or Staurosporine as a control. All inhibitors
were sourced from Cayman Chemical (Ann Arbor, MI), and were used for a period of 24
hours. As OSMI-1 and Thiamet-G were reconstituted in DMSO (Fisher Scientific), at
1000X, control wells of GCs were also spiked with 0.1% DMSO. After 24 hours of
treatment, GC proliferation was measured using the CellTiter 96® AQueous One
Solution Cell Proliferation Assay (MTS) kit following manufacturer instructions
(Promega, Madison, WI) including the use of a Synergy HT Plate Reader (BioTek).
Proliferation was measured 4 hours after the addition of the MTS Reagent. As a result of
limited cell number in GCs from large follicles, minimal dosages were evaluated
3.1.2.3 Statistics
A repeated measures one-way ANOVA with the Geisser- Greenhouse correction
followed by Dunnett’s multiple comparisons was used to assess cell proliferation
measured by MTS assay. Significant differences were recognized as P<0.05. Different
letters denote differences between treatments. Tests were performed using GraphPad
Prism 8 statistical software.
3.1.2 Results
3.1.2.1 Enzymatic inhibitors impair granulosa cell proliferation
As shown in Figure 1, the OGA inhibitor, Thiamet-G, had no effect on GC proliferation
in either follicle size (P>0,05, n=6 expts.). The OGT inhibitor, OSMI-1, impaired
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proliferation at both 25 and 50 µM in small follicles, with no differences between the two
doses (P<0.06, n=6 expts.), but had no effect on GC proliferation in large follicles
(P>0,05, n=6 expts.).

Figure 1. Effects of Thiamet-G and OSMI-1 on GC proliferation. Concentrations of
inhibitors are shown, with treatment of cells for 24 hours. Staurosporine (0.8 μM)
was used as a control. Absorbance measured at 490 nm in GCs of (A) small follicles
or (B) large follicles. Results representative of n=6 independent experiments, run in
triplicate. Letters denote differences at P<0.05.
3.1.3 Discussion and Conclusions
Working concentrations of the small molecule inhibitors OSMI-1 and Thiamet-G
were selected for the current experiments based upon those used previously by published
studies in the literature (Zhu-Mauldin et al., 2012; Ortiz-Meoz et al., 2015; Wani et al.,
2017; Jaskiewicz and Townson, 2019; Zhou et al., 2019). The concentrations of ThiametG range from 0.25-10 µM (Zhu-Mauldin et al., 2012; Wani et al., 2017; Jaskiewicz and
Townson, 2019; Zhou et al., 2019). Working concentrations of OSMI-1 vary from 10 to
100 µM, with the optimal dose for OSMI-1 in both studies at 50 µM (Ortiz-Meoz et al.,
2015; Jaskiewicz and Townson, 2019).
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Although Thiamet-G had no measurable effect on GC proliferation. Visual
observations here and information reported in the literature led to the selection of an
average dose of 2.5 µM for further experiments. This dose did in fact increase cellular
expression of O-GlcNAcylation in GCs from both small and large follicles but failed to
influence cell proliferation. Conversely, OSMI-1 impaired cell proliferation at both doses
tested. The higher concentration (50 µM) was selected for subsequent experiments,
however, based off its obvious effect to impair O-GlcNAcylation.
3.2 Effects of AMPK activation on O-GlcNAcylation
3.2.1 Abstract
O-GlcNAcylation is considered a nutrient sensor that can regulate cellular
processes such as metabolism, signal transduction, and proliferation. Other nutrient
sensing pathways exist and are active in granulosa cells (GC), including AMPK, mTOR,
and IIS. These pathways are sensitive to different cellular concentrations of nutrients and
each function to maintain cellular homeostasis. Some nutrient sensors, such as the mTOR
are reliant on signals from other nutrient sensors such as AMPK and IIS. Recently,
reports indicate that O-GlcNAcylation and AMPK may also exert overlapping regulation
and nutrient-sensing actions. Here, the effects of AMPK on GC O-GlcNAcylation were
explored using Metformin as an AMPK activating agent. Bovine ovary pairs
morphologically staged to the mid-to-late estrous period were used. GCs were aspirated
from small (3-5mm) and large (>10mm) follicles. GCs were seeded into T25 flasks or 96
well plates and treated with Metformin (10 mM). After 24 hours, GCs were lysed for
immunoblotting or proliferation was measured with MTS assay. Activation of AMPK by
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Metformin did not affect O-GlcNAcylation within GCs of either follicle size (P>0.05,
n=5 expts.). However, Metformin did impair GC proliferation of small follicles (P<0.05,
n=4 expts.), but had no effect on GCs of large follicles (P>0.05, n=4 expts.).

3.2.2 Introduction
AMP- activated protein kinase (AMPK) and O-GlcNAcylation are both
considered nutrient sensing mechanisms in the cell, as they are highly dependent on
nutrient availability for their functions. AMPK is an energy sensor that is activated by
low energy status of a cell (i.e., low ATP, low glucose, high AMP or ADP). Activation of
AMPK promotes ATP production by increasing the activity of catabolic processes
including glycolysis, fatty acid uptake/oxidation, and mitochondrial metabolism (Ke et
al., 2018). Concomitantly, AMPK activation inhibits cellular process that utilize ATP
such as fatty acid, cholesterol, and protein synthesis (Ke et al., 2018). O-GlcNAcylation
is responsive to concentrations of cellular glucose and uses UDP-GlcNAc from the
hexosamine biosynthesis pathway as a substrate to add GlcNAc sugars to
serine/threonine residues of nuclear and cellular proteins. Unlike O-GlcNAcylation,
AMPK is well studied in the literature, especially as it relates to granulosa cell function
(Dupont & Scaramuzzi, 2016; Kayampilly & Menon, 2009; Tosca et al., 2005, 2010).
AMPK activation suppresses peptide hormones, growth factors, cytokines and
chemokines, all of which contribute to cell growth. For example, activation of AMPK
inhibits proliferation and steroidogenic capacity of granulosa cells (Tosca et al., 2007;
Tosca et al., 2005). AMPK also decreases aromatase activity, thus impairing estradiol
57

production by bovine granulosa cells. In rats, AMPK inhibits progesterone synthesis by
granulosa cells, specifically by impairing cytochrome P450 and StAR enzymes (Tosca et
al., 2006). Additional effects of metformin include inhibition of MAPK, ERK1/2 and
ribosomal protein S6 kinase (p90rsk) phosphorylation in response to IGF-1 (Tosca et al.,
2010).
Recently, crosstalk between AMPK and O-GlcNAcylation has become evident.
AMPK is a target for O-GlcNAcylation, and the enzymes regulating O-GlcNAcylation,
including GFAT and OGT, are in turn phosphorylated by AMPK (Eguchi et al., 2009b;
Bullen et al., 2014; Gélinas et al., 2018). The aims of the study were to determine the
effects of AMPK activation via Metformin on global GC O-GlcNAcylation and
proliferation. Here, it was hypothesized that Metformin would decrease OGlcNAcylation in bovine GCs and impair GC proliferation.
3.2.3 Materials and Methods
3.2.3.1 Granulosa Cell Isolation
Pairs of bovine ovaries were collected from an abattoir (Champlain Beef, Whitehall, NY)
and transported to the laboratory in 0.9% sterile saline with antibiotic-antimycotic
(Gibco, Gaithersburg, MD) at room temperature for processing within 4-6 hours of
slaughter. The ovaries were morphologically staged to the estrous cycle based upon the
visual appearance of the corpus luteum (Ireland et al., 1980). Only ovaries within the
mid-to-late estrous cycle, were used. Small antral follicles (3-5 mm) (12-24 follicles per
ovary pair) were aspirated with a 21-gauge needle and 3mL luer lock syringe (BD)and
the granulosa cells (GCs) were pooled into a single sample. Large antral follicles (>10
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mm) were dissected from the ovary and aspirated to obtain GCs. Only the largest follicle
from each ovary pair was aspirated for collection. After aspiration of the large follicles,
the follicles were then sliced and scraped with a 5 mm rubber policeman. All samples
were centrifuged at 84 x g for 10 minutes at 4◦C to separate GCs from the follicular fluid.
3.2.3.2 Granulosa Cell Culture
Bovine GCs were collected as described above and seeded into T25 flasks (Corning,
Tewksbury, MA) in 1:1 DMEM/F12 (Gibco) + 10% fetal bovine serum (Corning) media
with the addition of an antibiotic-antimycotic regimen (10,000 units/mL of penicillin,
10,000 µg/mL of streptomycin, and 25 µg/mL of Gibco Amphotericin B) (Gibco). Cells
were grown for 72 hours, transitioned to serum-free DMEM/F12 media containing
insulin (100ng/mL)-transferrin (55ng/mL)-selenium (6.7pg/mL) (ITS) and were treated
with the AMPK activator, Metformin (10mM) (Cayman Chemical, Ann Arbor, MI)
(Tosca et al., 2010), for a period of 24 hours. Following treatment, flasks were placed on
ice and washed three times with 1 mL PBS prior to GC lysis by RIPA buffer. Next, the
PBS was removed and 200-500 µL of RIPA lysis buffer was added for 10 minutes.
Flasks were then scraped with a cell scraper to remove the GCs from the bottom of the
flasks. The GCs were collected into 1.5mL microcentrifuge tubes and further lysed by
aspirating through a 27-gauge needle (BD). Samples were vortexed for 15 seconds and
centrifuged at 15,294 x g for 10 minutes. The supernatant was removed, and protein was
standardized using a bicinchoninic acid (BCA) colorimetric assay (Thermo Scientific)
following manufacturer’s instructions. Absorbance at 562 nm was measured by the
Synergy HT Plate Reader (Biotek, Winooski, VT). Electrophoresis and immunoblotting
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of proteins from cultured cell lysates were conducted essentially as described above. In
this instance, however, protein was quantified using BCA assay and samples were diluted
in Lamelli sample buffer and boiled at 100◦ C for 1-3 minutes. 10 ng of protein was
loaded into each well (25 μL total volume loaded per well). Immunoblotting and
densitometric analyses were performed as described above and performed in triplicate.
3.2.3.3 Immunoblotting
Lysates of GCs from small and large follicles were used. Protein extracts were separated
on precast, stain free 10% gels (BioRad, Hercules, CA). Following electrophoretic
separation, gels were activated and imaged for total protein on the BioRad ChemiDoc
Imaging System. Proteins were transferred to a PVDF membrane (BioRad) using a semidry transfer system at 45mA for 1 hour (Hoefer, Holliston, MA). Post transfer, the gels
were again imaged on the ChemiDoc Imaging System (BioRad) to ensure complete
transfer of separated proteins. Following protein transfer, the PVDF membranes were
blocked in Tris-buffered saline (TBS) blocking buffer containing 5% BSA and
0.2%Tween 20 (TBST; Fisher Bioreagents, Pittsburgh, PA) for 3 hours on a platform
rocker at room temperature. Membranes were incubated overnight at 4◦ C with mouse
anti-O-GlcNAc (1:2500, CTD 110.6) primary antibody from Cell Signaling Technology
(Danvers, MA). Following overnight incubation, membranes were washed with TBST
under agitation in the following order: 2X 10-30 seconds, 1X for 15-minutes and 3X for
5-minutes. The membranes were then incubated in secondary antibody for 1 hour on a
platform rocker at room temperature. Goat-anti-mouse (1:5000) horseradish peroxidase
(HRP) conjugated secondary antibody from Santa Cruz Biotechnologies (Dallas, TX)
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was used. The membranes were washed as described above and were then incubated in
Clarity Western ECL Blotting substrate (BioRad) for 5 minutes. Immunodetectable
proteins were imaged on the ChemiDoc Imaging System (BioRad). After imaging, the
membranes were stripped using Restore Western Blot Stripping Buffer (Thermo
Scientific) per manufacturer’s instructions and reprobed for OGT using the methods
described above. However, the membranes were placed in blocking buffer for 3 hours at
room temperature prior to re-probing. O-GlcNAc and OGT protein values were
normalized to total protein within the gels prior to immunoblotting. Images were
analyzed using Image J (National Institute of Health) for protein quantification.

3.2.3.4 Granulosa Cell Proliferation Assay
Bovine GCs were collected as described above and seeded at 5000 viable cells/well into
96 well plates (Corning, Tewksbury, MA) in 1:1 DMEM/F12 (Gibco) + 10% fetal bovine
serum (Corning) media with the addition of an antibiotic-antimycotic regimen (Gibco).
Cells were grown for 36 hours, transitioned to serum-free DMEM/F12 media containing
insulin (100ng/mL)-transferrin (55ng/mL)-selenium (6.7pg/mL) (ITS) and were treated
Metformin (10 mM) (Cayman Chemical, Ann Arbor, MI) for a period of 24 hours. After
24 hours of treatment, GC proliferation was measured using the CellTiter 96® AQueous
One Solution Cell Proliferation Assay (MTS) kit following manufacturer instructions
(Promega, Madison, WI) including the use of a Synergy HT Plate Reader. Proliferation
was measured 4 hours after the addition of the MTS Reagent.
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3.2.3.5 Statistics
A repeated measures one-way ANOVA with the Geisser- Greenhouse correction
followed by Dunnett’s multiple comparisons was used to assess cell proliferation
measured by MTS assay as well as changes in O-GlcNAcylation relative to treatment.
Significant differences were recognized as P<0.05. Asterisks denote differences from
control. Tests were performed using GraphPad Prism 8 statistical software.
3.2.4 Results
3.2.4.1 No effect of AMPK activation on O-GlcNAcylation
AMPK activation by Metformin (10mM) did not affect O-GlcNAcylation in GCs from
either follicle size (P>0.05, n=5 expts.)

Figure 2. Effects of Metformin on GC O-GlcNAcylation. (A) Immunoblots of GCs
from small (SF) or large (LF) follicles probed for O-GlcNAcylation following 24
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hours of treatment with Metformin (10 mM). (B) Densitometric analysis of OGlcNAcylated proteins in bovine granulosa cells relative to total protein. Results
represent n=5 independent experiments run in triplicate, with the mean +/- SEM
signal intensity shown.
3.2.4.2 Metformin impairs granulosa cell proliferation
Treatment with Metformin (10 mM), impaired GC proliferation of small follicles
(P<0.05, n=5 expts.) but had no effect on GCs of large follicles (P>0.05, n=5 expts.).

Figure 3. Effects of Metformin on GC proliferation. (A) Absorbance measured at
490 nm in GCs of small follicles or large follicles. (B) Photomicrographs of GC
culture following 24 hours treatment at 10X magnification. Results representative of
n=4 independent experiments, run in triplicate. Letters denote differences at P<0.05.
3.2.5 Discussion
AMPK is a widely studied energy sensor of cells, typically activated to slow or
inhibit the progression of disease in response to energy depletion and cellular stress. In
contrast, upregulation of O-GlcNAcylation occurs during nutrient excess, and promotes
the development of disease. For instance, O-GlcNAcylation is typically upregulated in
cancer cells and promotes their proliferation and survival. This is exactly the opposite of
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what has been observed with AMPK activation. Dysregulated O-GlcNAcylation is also
implicated in diabetes and cardiovascular disease; whereas AMPK typically exerts
protective effects during disease states. This interplay between the two pathways suggests
that they might regulate the activities of each other. For instance, O-GlcNAcylation is
conducive to insulin resistance and glucotoxicity; whereas AMPK is typically considered
beneficial to diabetic pathologies (Copeland et al., 2008; Tosca et al., 2010). This benefit
of AMPK activation is the premise behind the use of Metformin as a therapeutic for
insulin resistance. Knockout of OGT (and thus, O-GlcNAcylation) in skeletal muscle of
mice leads to lower blood glucose during exercise and reduced occurrence of insulin
resistance (Murata et al., 2018). Higher AMPK expression and greater AMPK activation
after exercise was observed in these mice. The authors postulated that the reduction in OGlcNAcylation in skeletal muscle had an anti-diabetic effect through the stimulation of
an AMPK-dependent mechanism (Murata et al., 2018).
The influence of AMPK on O-GlcNAcylation via the hexosamine biosynthesis
pathway is also evident. In human endothelial cells, and cardiomyocytes, AMPK inhibits
the activity of GFAT, the rate-limiting enzyme controlling the flux of glucose into the
pathway. AMPK phosphorylates GFAT, suppressing its activity and significantly
lowering O-GlcNAcylation levels (Eguchi et al., 2009b; Zibrova et al., 2017; Gélinas et
al., 2018). AMPK also phosphorylates OGT, the enzyme that adds GlcNAc sugars onto
proteins. Although it does not seem to directly hinder its enzymatic activity,
phosphorylation of OGT by AMPK impacts its cellular localization and specificity,
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partially by competing with the phosphorylation site of proteins OGT would otherwise
target (Xu et al., 2012; Bullen et al., 2014; Wang et al., 2017a).
No direct interactions between OGA and AMPK have been observed, however,
AMPK knockout mice have significantly elevated O-GlcNAcylation, which is partially a
result of downregulation of OGA (Gélinas et al., 2018).
O-GlcNAcylation influences AMPK actions as well. AMPK is O-GlcNAcylated
by OGT. In embryonic fibroblasts, OGT stimulates AMPK activity by targeting
APMKα1 as shown in OGT knockout mice (Xu et al., 2014). AMPKγ is also OGlcNAcylated (Bullen et al., 2014). Surprisingly, this was observed during an activated
state of AMPK, in which glucose concentrations would have been expected to be low.
However, in the inactive state, the AMPK isoform is not O-GlcNAcylated suggesting that
AMPK may need to be active to undergo O-GlcNAcylation (Bullen et al., 2014).
In the current study, Metformin was used to activate AMPK based upon its known
effect to impair granulosa cell proliferation (Tosca et al., 2010). Metformin is also used to
treat polycystic ovarian syndrome (Lashen, 2010). It promotes insulin sensitivity, acting
in opposition to the putative role of O-GlcNAcylation in insulin resistance (Giannarelli et
al., 2003). In the present study, activation of AMPK by Metformin (10 mM) did not
affect O-GlcNAcylation of bovine granulosa cells. However, confirmation of AMPK
activity was not assessed here, and assurance that Metformin stimulated AMPK activity
was not known. Thus, further experiments may need to confirm this, or use a more
specific AMPK activator, such as A-769662 or AMPK Signaling Activator 1. However,
in the current study it was known that Metformin did exert an effect, as it impaired
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granulosa cell proliferation, as expected. As Metformin is widely used to treat PCOS, it
may be beneficial to further investigate the effects of Metformin on O-GlcNAcylation,
separate from its connection to AMPK.

CHAPTER 4: PERSPECTIVES AND CONSIDERATIONS
4.1 Limitations
It is acknowledged that a limitation of the current study is the use of
slaughterhouse ovaries. The ovaries obtained are not accompanied by any information
pertaining to the reproductive status of the cow, such as breed, age, parity, diseases, or
stage of estrous cycle/pregnancy. In the present study, the ovaries were staged based
upon the presence/appearance of the corpus luteum, but these techniques lack the
accuracy of tracking live animals by palpation or transrectal ultrasonography. Thus,
ascertaining the precise stage of the estrous cycle is virtually impossible. Additionally,
the use of slaughterhouse ovaries eliminates the possibility of investigating physiological
processes in a given cow sequentially.
Another limitation of this work is the use of cell culture. Cell culture poses its
own limitations in that cells phenotypically change in culture. They may begin to
differentiate and lose characteristics of granulosa cells the longer they remain in culture.
Specifically, with granulosa cells, long term culture often results in spontaneous
luteinization (Gutiérrez et al., 1997). The culture system used herein includes the use of
FBS, which favors luteinization. The two-dimensional plastic environment of the culture
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flask also does not resemble the three-dimensional environment of the follicle, which
makes it difficult to make direct connections to animal studies or in vivo environments.
Our initial experiment of characterizing O-GlcNAcylation in different sized follicles
utilized fresh cells immediately lysed upon collection. Subsequent experiments, however,
utilized cell culture to invoke the various treatments and manipulated O-GlcNAcylation.
The defined environment used for cell culture here also excluded an interaction
with the COC, theca cells, and follicular fluid. It is likely that these losses of cell-cell
interactions impact many processes including metabolic processes like O-GlcNAcylation
and steroid synthesis.
To address some of these limitations about culture-induced phenotype, removal
of FBS from the culture medium would be helpful. Baufeld and Vanselow proposed a
new culture method that helps retain granulosa cell phenotype and supports estradiol
secretion (Baufeld and Vanselow, 2018). This medium does not contain FBS, but instead
contains insulin, FSH, IGF-1, bovine albumin, and androstenedione. This culture method
utilizes FSH and insulin stimulation to mimic the estradiol active state of in vivo follicles
and this stimulation is conducive of androstenedione aromatization to estradiol and
supports growth. The removal of serum from culture further attenuates a steroid active
culture. In attempts to make the cell culture media/environment more like the in vivo
environment, a full analysis of nutrients, metabolites, and hormones, and their
concentrations present in follicular fluid could be done, with modifications to media
made. Further unknowns can be overcome either by the immediate use of cells from
ovariectomized cows with known reproductive status or the collection of granulosa cells
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by transvaginal follicular aspiration in live animals. Further, here Metformin was used to
activate AMPK, but it is not a specific activator of AMPK. Although Metformin impaired
granulosa cell proliferation as expected, using a specific agonist including, A-769662 or
AMPK Signaling Activator 1, to ensure AMPK activation would add support to the
results.

4.2 Future Perspectives
In this study, O-GlcNAcylation was evident in granulosa cells of bovine antral
follicles and, interestingly, changed with follicle size and follicular fluid glucose
concentrations. Future studies to identify the proteins O-GlcNAcylated would be
insightful, and perhaps lead to new ideas about the role of O-GlcNAcylation in follicle
growth. In the current study, distinct bands of O-GlcNAcylation were evident, and these
bands of proteins changed as a result of physiological circumstances (e.g., small vs large
follicles) and experimental manipulation (e.g., effects of the OSMI-1 inhibitor).
Identifying the specific proteins targeted for O-GlcNAcylation would provide further
insight on the mechanistic aspects of O-GlcNAcylation on granulosa cell proliferation
and possibly folliculogenesis. Characterization of the metabolism of granulosa cells of
different follicles sizes (e.g., glucose/lactate metabolism, Seahorse analyses), would test
the hypothesis that granulosa cells of small follicles favor glycolytic metabolism over
oxidative phosphorylation. Similar experiments using granulosa cells of large follicles
could be implemented to determine if the cells favor oxidative phosphorylation, and
whether such metabolism is critical for differentiation.
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To further investigate O-GlcNAcylation’s role in folliculogenesis, performing a
similar study to this in both theca cells and oocytes in which O-GlcNAcylation was
characterized in both small and large follicles would provide a more complete picture of
the follicle during growth. Granulosa, theca, and oocytes are known to communicate
during growth. In granulosa cells the O-GlcNAc status decreased with follicle size, and it
would be interesting to determine if this is synonymous throughout the cells of the
follicle. Specifically, granulosa cells provide glycolytic substrates to oocytes (Sugiura et
al., 2005) and O-GlcNAcylation is evident in oocytes.
Importantly, the effects of O-GlcNAcylation on steroid production should be
assessed. To start, future studies (in theca and/or granulosa) could determine the effects
of up-or-down regulation of O-GlcNAcylation on subsequent androstenedione and
estradiol production. Further, studies on the O-GlcNAcylation status of enzymes
(expressed in theca or granulosa cells) such as StAR, 3β-HSD, CYP17A1, 17β-HSB or
aromatase, may unveil the potential steroidogenic changes that could occur in response
manipulated O-GlcNAcylation. Estrogen receptor (ER) α and β are O-GlcNAcylated
(Cheng and Hart, 2000; Kanwal et al., 2013). ER receptors are present in bovine theca
cells, granulosa cells, and oocytes and expression varies as follicles grow (Salvetti et al.,
2007; Pohler et al., 2012; Rovani et al., 2014). However, O-GlcNAcylation of these
receptors has not been determined and provides room for future studies. Lastly, OGlcNAcylation is postulated to be a nutrient sensing mechanism. In vitro work completed
in the current study provided the basic methodology necessary to translate this work into
an in vivo environment. Studies in which O-GlcNAcylation is characterized under
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varying levels of an animal’s nutrient status (positive or negative energy balance) would
allow for further insight on how an animal’s nutrient status interacts with its reproductive
capacity and the sensitivity of O-GlcNAcylation in granulosa cells. From these in vivo
studies, direct observations could be made to connect the steroidogenic capacity
(estradiol vs progesterone secretion) and fate/health (ovulatory vs non-ovulatory,
dominant vs subordinate, cystic) of the follicle to the level of O-GlcNAcylation in
granulosa cells observed.

4.3 Applications
The results of this study provide many opportunities for further work to evaluate
the role of O-GlcNAcylation in ovarian function and dairy reproduction. The broader
impacts of this work could contribute to a better understanding of the cellular
mechanisms underlying follicular growth and ovulation, which have direct impacts on the
reproductive efficiency of dairy cattle. Greater understanding of the role of OGlcNAcylation in reproduction could also provide researchers with avenues for
therapeutic intervention and treatment of subfertility or infertility. For example, OGlcNAcylation is implicated in human insulin resistance, which is a similar condition to
what occurs in the postpartum dairy cow. If O-GlcNAcylation is determined to act in the
same manner in granulosa cells during this insulin resistant state, approaches to treat the
problem could be developed, which would potentially decrease the calving to conception
interval.
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